Introduction {#sec1}
============

The cyanosilylation reaction is an important C--C bond-forming reaction that provides access to a variety of fine and specialty chemicals, including a wide range of polyfuctionalized building blocks like α-hydroxy acids, β-amino alcohols, and also the biologically active compounds.^[@ref1]^ The reaction proceeds with the protection of a resulting alcohol functional moiety through O-silylated cyanohydrin (*O*-TMS) formation that allows further transformation to other functionalities. The reaction is valued for its convenient atom-economic approach and has been studied extensively in the areas of heterogeneous catalysis;^[@ref2]−[@ref4]^ homogeneous catalysis,^[@ref5]−[@ref11]^ including ligand-assisted catalysis;^[@ref12],[@ref13]^ organocatalysis;^[@ref14]−[@ref16]^ and those by simple metal salts.^[@ref17],[@ref18]^ In this regard, it is worth noting that despite the fact that the transition-metal N-heterocyclic carbene (NHC) complexes have been exceptionally successful in homogeneous catalysis,^[@ref19]−[@ref22]^ their applications in the catalysis of cyanosilylation reaction surprisingly remains unexplored to date and hence we became interested in pursuing the same.

With our interest in expanding the domains of the transition-metal N-heterocyclic carbene complexes in biomedical applications^[@ref23]−[@ref25]^ and in chemical catalysis,^[@ref26]−[@ref29]^ spanning over the polymerization reactions^[@ref30]−[@ref33]^ to a variety of C--C^[@ref34]−[@ref39]^ and C--N^[@ref40]−[@ref42]^ bond-forming reactions, bifunctional catalysis^[@ref26],[@ref43]−[@ref46]^ to the transfer hydrogenation reactions^[@ref47]^ and tandem reactions,^[@ref48]^ and asymmetric catalysis,^[@ref44],[@ref47]^ we became interested in exploring the potential of the ruthenium N-heterocyclic carbene complexes in the cyanosilylation reaction. In particular, we set out to employ the ruthenium complexes of the benzimidazole-derived N/O-functionalized N-heterocyclic carbene ligands for the cyanosilylation reaction of the aromatic aldehydes.

Herein, in this manuscript, we report a series of ruthenium complexes, \[{1-(*N*-R~1~-2-acetamido)-3-(R~2~)-benzimidazol-2-ylidine}Ru(*p*-cymene)Cl\]Cl, where {R~1~ = 2,6-(*i*-Pr)~2~C~6~H~3~, R~2~ = *i*-Pr (**1c**); R~1~ = 2,6-(*i*-Pr)~2~C~6~H~3~, R~2~ = Et (**2c**); R~1~ = 2,4,6-(CH~3~)~3~C~6~H~2~, R~2~ = Et (**3c**)} ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}) of the benzimidazole-derived N-heterocyclic carbene ligands that performed the cyanosilylation reaction of the aromatic aldehydes at room temperature under solvent-free conditions. The ruthenium (**1**--**3**)**c** complexes were prepared by following a transmetallation route from the silver (**1**--**3**)**b** analogues ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}).

![Silver and ruthenium complexes of benzimidazole-derived N/O-functionalized N-heterocyclic carbenes.](ao-2017-02090s_0023){#fig1}

![Synthetic Route for Ruthenium (**1**--**3**)**c** Complexes](ao-2017-02090s_0005){#sch1}

Results and Discussion {#sec2}
======================

Benzimidazole-derived *N*-heterocyclic ligands, namely, 1-(*N*-R~1~-2-acetamido)-3-(R~2~)-benzimidazol-2-ylidene {R~1~ = 2,6-(*i*-Pr)~2~C~6~H~3~, R~2~ = *i*-Pr (**1a**); R~1~ = 2,6-(*i*-Pr)~2~C~6~H~3~, R~2~ = Et (**2a**); R~1~ = 2,4,6-(CH~3~)~3~C~6~H~2~, R~2~ = Et (**3a**)}, were constructed by incorporation of N/O-functionalized side arms on the benzimidazole fragments. Specifically, the reaction of 2-chloro-*N*-R~1~-acetamide \[R~1~ = 2,6-(*i*-Pr)~2~C~6~H~3~, 2,4,6-(CH~3~)~3~C~6~H~2~\] with *N*-1-R~2~-benzimidazole (R~2~ = *i*-Pr, Et) gave 1-(*N*-R~1~-2-acetamido)-3-(R~2~)-benzimidazolium chloride salts {R~1~ = 2,6-(*i*-Pr)~2~C~6~H~3~, R~2~ = *i*-Pr (**1a**); R~1~ = 2,6-(*i*-Pr)~2~C~6~H~3~, R~2~ = Et (**2a**); R~1~ = 2,4,6-(CH~3~)~3~C~6~H~2~, R~2~ = Et (**3a**)} in ca. 71--79% yields. Subsequently, the reaction of the benzimidazolium chloride salts (**1**--**3**)**a** with Ag~2~O in CH~2~Cl~2~ under the exclusion of light at ambient temperature resulted in the formation of corresponding Ag--NHC complexes (**1**--**3**)**b** in ca. 88--95% yields. Quite expectedly, the characteristic Ag--C~carbene~ resonances of the silver complexes (**1**--**3**)**b** appeared highly downfield shift at ca. δ 183.3--189.1 ppm in the ^13^C{^1^H} NMR spectrum.

The molecular structure of a representative **2b** complex ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"} and [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}) has been determined by single-crystal X-ray diffraction studies that confirmed the dimeric macrometallacyclic nature of the silver complex of the type {1-(*N*-R~2~-2-acetamido)-3-(R~1~)-benzimidazol-2-ylidine}~2~Ag~2~ \[R~1~ = Et; R~2~ = 2,6-(*i*-Pr)~2~C~6~H~3~\], similar to that observed earlier for the related silver analogues.^[@ref49]−[@ref51]^ The geometry around each of the two silver atoms was nearly linear \[∠C(1)--Ag(1)--N(3)^i^ = 168.61(8)°\] with the metal atom bound to amido--*N* at one end and to C~carbene~ atom at the other end. The Ag--C~carbene~ bond distance of 2.073(2) Å was slightly shorter than the sum of the individual covalent radii of C and Ag (2.18 Å)^[@ref52]^ but compared well to that of the related analogues, namely, 1-(R~3~)-3-{*N*-(2,6-di-*i*-propylphenylacetamido)-imidazol-2-ylidine}~2~Ag~2~ {R~3~ = *i*-Pr \[2.066(8) Å\], *t*-Bu \[2.032(4) Å\]}.^[@ref49]^ Similarly, the Ag--N~amido~ distance of 2.0898(18) Å too was observed to be shorter than the sum of the individual covalent radii of N and Ag (2.16 Å)^[@ref52]^ and also comparable to that of the related complexes, 1-(R~3~)-3-{*N*-(2,6-di-*i*-propylphenylacetamido)-imidazol-2-ylidine}~2~Ag~2~ {R~3~ = *i*-Pr \[2.084(6) Å\], *t*-Bu \[2.073(3) Å\]}.^[@ref49]^

![ORTEP of **2b** ellipsoids are at 50% probability level. All hydrogen atoms have been omitted for clarity. Selected bond lengths (Å) and angles (deg): Ag(1)--C(1) 2.073(2), Ag(1)--N(3)^i^ 2.0898(18), Ag(1)--Ag(1)^i^ 3.1894(3), O(1)--C(11) 1.230(3), N(1)-C(1) 1.345(3), N(1)--C(2) 1.387(3), N(2)--C(10) 1.453(3), N(3)--C(11) 1.328(3), N(3)--Ag(1)^i^ 2.0897(18), C(10)--C(11) 1.539(3), C(1)--Ag(1)--N(3)^i^ 168.61(8), C(1)--Ag(1)--Ag(1)^i^ 95.89(6), N(3)^i^--Ag(1)--Ag(1)^i^ 95.23(5), C(1)--N(1)--C(2) 110.7(2), C(1)--N(2)--C(10) 124.5(2), C(11)--N(3)--Ag(1)^i^ 129.68(15), N(1)--C(1)--N(2) 106.2(2), N(1)--C(1)--Ag(1) 126.96(17), N(2)--C(1)--Ag(1) 126.46(17), N(1)--C(2)--C(3) 131.7(2), N(2)--C(10)--C(11) 108.71(18), O(1)--C(11)--N(3) 127.0(2), O(1)--C(11)--C(10) 118.2(2), N(3)--C(11)--C(10) 114.7(2).](ao-2017-02090s_0001){#fig2}

Of particular interest is the Ag···Ag distance of 3.1894(3) Å in **2b**, which is significantly shorter than twice the van der Waals radius of Ag (1.72 Å),^[@ref53]^ suggesting the presence of argentophilic *d*^10^···*d*^10^ interaction. Further corroboration came from the photoluminescence studies performed on all of the silver (**1**--**3**)**b** complexes in both the CHCl~3~ solution and the solid state at room temperature. Specifically, upon excitation at 270 nm, the silver (**1**--**3**)**b** complexes showed characteristic low-energy emissions at ca. 534--536 nm in the CHCl~3~ solution and at ca. 482--487 and 530--533 nm in the solid state assignable to the argentophilic *d*^10^···*d*^10^ interaction ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, [Figures [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}, [4](#fig4){ref-type="fig"}, and [S1--S4](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b02090/suppl_file/ao7b02090_si_001.pdf) in the Supporting Information). Finally, ligand-based emissions appeared at high energy and ca. 302--386 nm for the silver (**1**--**3**)**b** complexes.

![Comparison of the emission spectra of the ligand (**2a**) and the Ag--NHC complex (**2b**) in CHCl~3~ at room temperature (excitation at 270 nm), in which the peak representing the Ag···Ag interaction is designated by an asterisk in the plot.](ao-2017-02090s_0002){#fig3}

![Comparison of the emission spectra of the ligand (**2a**) and the Ag--NHC complex (**2b**) in solid state at room temperature (excitation at 270 nm), in which the peak representing the Ag···Ag interaction is designated by an asterisk in the plot.](ao-2017-02090s_0003){#fig4}

###### Absorption and Emission Data for Compounds **1a**, **1b**, **2a**, **2b**, **3a**, and **3b**

                         room temperature   
  -------- ------------- ------------------ ---------------
  **1a**   271 (4207)    302, 359           353
  **1b**   276 (8850)    302, 361, 535      388, 487, 533
  **2a**   270 (3840)    360                358
  **2b**   276 (10520)   360, 534           386, 482, 530
  **3a**   271 (4187)    354                361
  **3b**   277 (9168)    316, 536           386, 487, 532

Excited at 270 nm and the spectrum recorded in CHCl~3~ at room temperature.

Excited at 270 nm and the spectrum recorded in solid state.

The Ag···Ag distance of 3.1894(3) Å and the corresponding emissions at 534 nm in CHCl~3~ and at 486 and 530 nm in the solid state at room temperature for the structurally characterized representative silver complex **2b** compare well with the related structurally characterized dinuclear silver complexes, namely, 1-(R~3~)-3-{*N*-(2,6-di-*i*-propylphenylacetamido)-imidazol-2-ylidine}~2~Ag~2~ \[R~3~ = *i*-Pr (emission at 647 nm in CHCl~3~ and 635 nm in solid state at room temperature for a Ag···Ag distance of 3.550 Å), *t*-Bu (emission at 630 nm in CHCl~3~ and 632 nm in solid state at room temperature for a Ag···Ag distance of 3.771 Å)\], and other related complexes.^[@ref49],[@ref54]^

Finally, the ruthenium complexes (**1**--**3**)**c** were obtained from silver complexes (**1**--**3**)**b** in ca. 67--80% yields by reaction with \[RuCl~2~(*p*-cymene)\]~2~ at room temperature. The ^1^H NMR spectra of the (**1**--**3**)**c** complexes showed the amido--N*[H]{.ul}* resonance at δ ca. 12.18--12.50 ppm, whereas the ^13^C{^1^H} NMR spectra showed the characteristic Ru--C~carbene~ resonance at δ ca. 187.6--189.1 ppm. Unlike the case of the benzimidazolium chloride salts (**1**--**3**)**a** and the silver (**1**--**3**)**b** complexes, for which the methylene (C*[H]{.ul}*~2~) resonances appeared as singlets at δ 5.96--6.05 and 5.28--5.36 ppm, respectively, the same for the ruthenium (**1**--**3**)**c** complexes appeared as diastereotopic doublets at δ 5.31 and 5.32 ppm (**1c**), δ 5.40 and 5.41 ppm (**2c**), and δ 5.18 and 5.02 ppm (**3c**), exhibiting two-bond (^2^*J*~H--H~) geminal coupling constants of 14--15 Hz in the ^1^H NMR spectra. The IR spectra of the (**1**--**3**)**c** complexes showed the amido--CO stretching frequency at ca. 1624--1627 cm^--1^, which is significantly at a lower energy with regard to the amido--CO stretching frequency of the free ligands, **1a** (1679 cm^--1^), **2a** (1679 cm^--1^), and **3a** (1690 cm^--1^), and has been ascribed to the coordination of amido--*O* atom to the ruthenium center in the (**1**--**3**)**c** complexes, as observed earlier.^[@ref55]^

The molecular structures of all of the three (**1**--**3**)**c** complexes ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"} and [Figures [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}--[7](#fig7){ref-type="fig"}) have been determined by single-crystal X-ray diffraction studies, which showed these complexes exhibiting a conventional "piano stool" structure with the ruthenium center being bound to η^6^-*p*-cymene, η^2^-amido-functionalized N-heterocyclic carbene ligand and chloride atoms. The Ru--C~carbene~ bond distances in **1c** \[2.0556(15) Å\], **2c** \[2.038(3) Å\], and **3c** \[2.0410(18) Å\] were slightly shorter than the sum of individual covalent radii of Ru and C atoms (2.19 Å)^[@ref52]^ but compared well with other reported analogues, namely, \[{1-(*N*-benzylacetamido)-3-(R~4~)-imidazol-2-ylidene}Ru(*p*-cymene)Cl\]Cl {R~4~ = Me \[2.0172(19) Å\], *i*-Pr \[2.033(5) Å\], and CH~2~Ph \[2.019(3) Å\]}^[@ref56]^ and \[{1-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)-3-(mesityl)-imidazol-2-ylidene}Ru(*p*-cymene)Cl\]PF~6~ \[2.038(3) Å\].^[@ref57]^ Likewise, the Ru--Cl bond distances in **1c** \[2.4041(4) Å\], **2c** \[2.3907(8) Å\], and **3c** \[2.4005(5) Å\] were in agreement with the related complexes \[{1-(*N*-benzylacetamido)-3-(R~4~)-imidazol-2-ylidene}Ru(*p*-cymene)Cl\]Cl {R~4~ = Me \[2.4256(14) Å\], *i*-Pr \[2.4325(8) Å\], and CH~2~Ph \[2.4404(7) Å\]},^[@ref56]^ \[{1-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)-3-(mesityl)-imidazol-2-ylidene}Ru(*p*-cymene)Cl\]PF~6~ \[2.420(1) Å\],^[@ref57]^ and the Ru--O~amido~ bond distances in **1c** \[2.1563(11) Å\], **2c** \[2.148(2) Å\], and **3c** \[2.1276(13) Å\] with a related complex \[{1-(*N*-benzylacetamido)-3-(pyridin-2-ylmethyl)-imidazol-2-ylidene}Ru(CH~3~CN)~2~(PPh~3~)\](PF~6~)~2~ \[2.143(4) Å\].^[@ref55]^

![ORTEP of **1c** ellipsoids are at 50% probability level. All hydrogen atoms (except H3) and co-crystalized CH~3~CN have been omitted for clarity. Selected bond lengths (Å) and angles (deg): Ru(1)--C(1) 2.0556(15), Ru(1)--O(1) 2.1563(11), Ru(1)--Cl(1) 2.4041(4), O(1)--C(12) 1.2551(19), N(3)--C(12) 1.325(2), N(3)--H(3) 0.8600, N(2)--C(1) 1.356(2), N(2)--C(11) 1.4555(19), N(1)--C(1) 1.360(2), C(11)--C(12) 1.510(2), C(1)--Ru(1)--O(1) 85.12(5), C(1)--Ru(1)--Cl(1) 84.06(4), O(1)--Ru(1)--Cl(1) 83.28(3), C(12)--O(1)--Ru(1) 124.67(11), C(12)--N(3)--H(3) 116.7, C(1)--N(2)--C(11) 123.77(13), N(2)--C(1)--N(1) 106.20(13), N(2)--C(11)--C(12) 109.90(12), O(1)--C(12)--C(11) 121.09(13), O(1)--C(12)--N(3) 123.67(14), N(3)--C(12)--C(11) 115.24(13), N(2)--C(1)--Ru(1) 121.49(11), N(1)--C(1)--Ru(1) 131.87(11).](ao-2017-02090s_0004){#fig5}

![ORTEP of **2c** ellipsoids are at 50% probability level. All hydrogen atoms (except H3) and co-crystalized CHCl~3~ have been omitted for clarity. Selected bond lengths (Å) and angles (deg): Ru(1)--C(1) 2.038(3), Ru(1)--O(1) 2.148(2), Ru(1)--Cl(1) 2.3907(8), O(1)--C(11) 1.256(3), N(3)--H(3) 0.8600, N(1)--C(1) 1.357(4), N(3)--C(11) 1.319(4), N(2)--C(1) 1.354(4), C(11)--C(10) 1.510(4), C(1)--Ru(1)--O(1) 82.78(10), N(1)--C(1)--Ru(1) 121.0(2), C(1)--Ru(1)--Cl(1) 88.23(9), O(1)--Ru(1)--Cl(1) 83.13(6), C(11)--O(1)--Ru(1) 122.66(19), C(1)--N(1)--C(10) 122.5(2), C(11)--N(3)--H(3) 118.5, O(1)--C(11)--N(3) 122.2(3), N(3)--C(11)--C(10) 117.0(2), N(1)--C(10)--C(11) 106.7(2), N(2)--C(1)--N(1) 106.2(3), N(2)--C(1)--Ru(1) 132.9(2).](ao-2017-02090s_0016){#fig6}

![ORTEP of **3c** ellipsoids are at 50% probability level. All hydrogen atoms (except H3) and co-crystalized H~2~O have been omitted for clarity. Selected bond lengths (Å) and angles (deg): Ru(1)--C(1) 2.0410(18), Ru(1)--O(1) 2.1276(13), Ru(1)--Cl(1) 2.4005(5), O(1)--C(11) 1.252(2), N(2)--C(1) 1.357(2), N(2)--C(10) 1.455(2), N(3)--C(11) 1.316(2), N(3)--H(3) 0.8600, N(1)--C(1) 1.354(2), C(10)--C(11) 1.510(3), C(1)--Ru(1)--O(1) 84.84(6), C(1)--Ru(1)--Cl(1) 85.87(5), O(1)--Ru(1)--Cl(1) 83.62(4), C(11)--O(1)--Ru(1) 125.03(12), C(1)--N(2)--C(10) 124.38(15), C(11)--N(3)--C(12) 126.19(16), C(11)--N(3)--H(3) 116.9, N(2)--C(10)--C(11) 111.33(16), N(1)--C(1)--N(2) 105.89(15), N(2)--C(1)--Ru(1) 121.97(14), N(1)--C(1)--Ru(1) 132.14(14), O(1)--C(11)--N(3) 122.65(17), O(1)--C(11)--C(10) 121.85(17), N(3)--C(11)--C(10) 115.46(16).](ao-2017-02090s_0021){#fig7}

###### X-ray Crystallographic Data of Ruthenium (**1**--**3**)**c** Complexes and Silver **2b** Complex

                                          **1c**                           **2c**                           **3c**                            **2b**
  --------------------------------------- -------------------------------- -------------------------------- --------------------------------- -------------------------------
  lattice                                 triclinic                        triclinic                        triclinic                         monoclinic
  empirical formula                       C~34~H~45~Cl~2~N~3~ORu·CH~3~CN   C~33~H~43~Cl~2~N~3~ORu·CHCl~3~   C~30~H~37~Cl~2~N~3~O~2~Ru·H~2~O   C~46~H~56~Ag~2~N~6~O~2~
  formula weight                          724.75                           789.04                           645.61                            940.70
  crystal size (mm^3^)                    0.139 × 0.132 × 0.086            0.245 × 0.115 × 0.089            0.203 × 0.093 × 0.083             0.396 × 0.296 × 0.230
  space group                             *P*1̅                             *P*1̅                             *P*1̅                              *P*2~1~/*n*
  *a* (Å)                                 11.6120(3)                       11.04197(15)                     9.9088(2)                         9.8105(3)
  *b* (Å)                                 13.3307(4)                       13.3361(3)                       11.7379(2)                        15.9779(3)
  *c* (Å)                                 13.8927(5)                       13.4517(3)                       14.6956(3)                        14.0138(4)
  α (deg)                                 62.692(3)                        69.6572(18)                      109.2536(19)                      90
  β (deg)                                 85.611(2)                        83.3894(13)                      99.6774(18)                       106.163(3)
  γ (deg)                                 70.196(3)                        82.6029(13)                      107.5084(18)                      90
  V (Å^3^)                                1789.82(11)                      1836.58(6)                       1469.48(5)                        2109.86(9)
  *Z*                                     2                                2                                2                                 2
  temperature (K)                         293(2)                           293(2)                           293(2)                            150(2)
  radiation (λ, Å)                        0.71073                          0.71073                          0.71073                           0.71073
  ρ (calcd) (g cm^--3^)                   1.345                            1.427                            1.459                             1.481
  absorption coefficient (mm^--1^)        0.620                            0.821                            0.747                             0.973
  θ range (deg)                           2.245--24.999                    2.596--24.999                    2.323--24.993                     2.601--24.998
  reflections collected                   45 279                           27 452                           15 201                            12 562
  data/restraints/parameters              6266/0/407                       6219/18/405                      5141/0/353                        3631/0/258
  independent reflections \[*R*~int~\]    6266 \[0.0396\]                  6219 \[0.0493\]                  5141 \[0.0377\]                   3631 \[0.0263\]
  completeness to θ = 25.000              99.5%                            96.2%                            99.3%                             97.6%
  final *R* indices \[*I* \> 2(σ)\]       *R*1 = 0.0222, w*R*2 = 0.0526    *R*1 = 0.0418, w*R*2 = 0.1010    *R*1 = 0.0248, w*R*2 = 0.0600     *R*1 = 0.0272, w*R*2 = 0.0715
  *R* indices (all data)                  *R*1 = 0.0243, w*R*2 = 0.0534    *R*1 = 0.0459, w*R*2 = 0.1035    *R*1 = 0.0293, w*R*2 = 0.0617     *R*1 = 0.0287, w*R*2 = 0.0723
  GOF                                     1.045                            1.037                            1.044                             1.056
  largest diff. peak and hole (eǺ^--3^)   0.314 and −0.499                 1.778 and −1.552                 0.447 and −0.649                  1.127 and −0.295

Quite significantly, the ruthenium (**1**--**3**)**c** complexes carried out the cyanosilylation of aryl aldehydes ([eq [1](#eq1){ref-type="disp-formula"}](#eq1){ref-type="disp-formula"}) and heteroaryl aldehydes ([eq [2](#eq2){ref-type="disp-formula"}](#eq2){ref-type="disp-formula"}) at room temperature under solvent-free conditions ([Tables [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"} and [4](#tbl4){ref-type="other"}). Specifically, catalyst optimization studies conducted on a representative pair of substrates, namely, benzaldehyde and trimethylsilyl cyanide (TMSCN), showed a maximum yield of 87% for the **1c** complex after 6 h of reaction time at 2 mol % of catalyst loading. The control experiment, when performed with \[Ru(*p*-cymene)Cl\]~2~ at the identical 2 mol % of the ruthenium loading, produced the corresponding product 2-phenyl-2-(trimethylsilyloxy)acetonitrile (**4**) in 30% yield under analogous reaction conditions and thereby upheld the amplification observed in the product yields (ca. 77--87%) in case of the (**1**--**3**)**c** complexes. The Hg drop experiment performed for the (**1**--**3**)**c** complexes showed nearly equal yields both in the presence and absence of Hg, thus indicating the homogeneous nature of catalysis. Substrate scope studies were subsequently performed for the ruthenium (**1**--**3**)**c** complexes for a variety of aryl aldehydes and heteroaryl aldehydes, namely, picolinaldehyde, furfural, and thiophene-2-aldehyde substrates, which gave good to excellent product yields. Interestingly, the **1c** complex, containing sterically demanding *i*-Pr group, gave better yields than the other two catalysts **2c** and **3c**.

###### Solvent-Free Cyanosilylation Reaction of Benzaldehyde and TMSCN Substrates Catalyzed by the Ruthenium (**1**--**3**)**c** Complexes[a](#t3fn1){ref-type="table-fn"}

![](ao-2017-02090s_0007){#fx13}

Reaction condition: benzaldehyde (0.106 g, 1.00 mmol), TMSCN (0.297 g, 3.00 mmol), with 2 mol % of catalyst, except entry 4 (1 mol %). Reaction time: 6 h, room temperature (a) isolated yields.

###### Selected Results for the Solvent-Free Cyanosilylation Reaction of Aryl Aldehydes, Including Heteroaryl Aldehydes and TMSCN Substrates, As Catalyzed by the Ruthenium (**1**--**3**)**c** Complexes[a](#t4fn1){ref-type="table-fn"}

![](ao-2017-02090s_0017){#fx14}

Reaction condition: Aryl aldehydes and heteroaryl aldehydes (1.00 mmol), TMSCN (0.297 g, 3.00 mmol), with 2 mol % of catalyst. Reaction time: 6 h, room temperature (a) isolated yield.

It is important to compare the catalytic activity of the ruthenium (**1**--**3**)**c** complexes with the others reported in the literature. In the absence of any report on the use of a ruthenium N-heterocyclic complex in the cyanosilylation reaction, the comparison is thus made with the structurally characterized examples of the transition-metal complexes of other ligands ([Table [5](#tbl5){ref-type="other"}](#tbl5){ref-type="other"}). For example, for the cyanosilylation of benzaldehyde with TMSCN, a ruthenium complex, namely, \[Ru(phgly)~2~(binap)\]/Li~2~CO~3~ (phgly = phenylglycinate, binap = 2,2′-bis(diphenylphosphanyl)-1,1′-binaphthyl),^[@ref8]^ exhibited 98% of the product yield at −78 °C after 12 h of reaction time at 0.01 mol % of catalyst loading. Likewise, at the same 0.01 mol % of the catalyst loading, another ruthenium complex, \[Ru{(*S*)-phgly}~2~{(*S*)-biphep}\]/Li~2~CO~3~ \[biphep = 2,2′-bis(diphenylphosphino)biphenyl\],^[@ref6]^ too gave a product yield of 99% at −78 °C after 6 h of reaction time. Both of these ruthenium complexes thus exhibited superior activities to our ruthenium (**1**--**3**)**c** complexes that exhibited ca. 77--87% yields at room temperature after 6 h of reaction time at a higher 2 mol % of catalyst loadings. However, a vanadyl salen complex^[@ref7]^ displayed 94% of the product yield at −20 °C after 24 h of reaction time at a 5 mol % of catalyst loading. Another iron complex, \[(Cp)~2~Fe\]PF~6~,^[@ref9]^ showed 94% of product yield at room temperature after 10 h of reaction time at a 2.5 mol % of catalyst loading under solvent-free condition.

###### Comparison of Cyanosilylation of Benzaldehyde with TMSCN in the Presence of Some of the Well-Known Structurally Characterized Catalysts

![](ao-2017-02090s_0024){#fx15}

Conclusions {#sec3}
===========

In summary, a series of three new N/O-functionalized benzimidazole-2-ylidene-based cationic ruthenium (**1**--**3**)**c** complexes have been synthesized by employing the transmetallation route from their corresponding silver (**1**--**3**)**b** complexes in good yields. The silver (**1**--**3**)**b** complexes exhibited argentophilic *d*^10^···*d*^10^ interaction as observed by the emission band(s) at ca. 534--536 nm in the CHCl~3~ solution and at ca. 482--487 and 530--533 nm in the solid state and also from the structural characterization of a representative silver complex **2b**, which showed a short Ag···Ag contact of 3.1894(3) Å in its dimeric macrometallacyclic structure. Structural characterization of the ruthenium (**1**--**3**)**c** complexes revealed the chelation of the N-heterocyclic carbene ligand to the metal center through an O~amido~ sidearm moiety and a carbene moiety. Significantly enough, the ruthenium (**1**--**3**)**c** complexes efficiently carried out the cyanosilylation of various aryl aldehydes and heteroaryl aldehydes at room temperature under solvent-free condition in good to excellent yields. Out of the three complexes, the ruthenium **1c** complex, containing sterically demanding *i*-Pr group, exhibited superior activity.

Experimental Section {#sec4}
====================

General Procedures {#sec4.1}
------------------

All of the experiments were performed using a glovebox and Schlenk techniques. Solvents were purified and degassed by standard procedures. 1-*i*-Propylbenzimidazole,^[@ref58]^ 1-ethyllbenzimidazole,^[@ref58]^ 2-chloro-*N*-mesitylacetamide,^[@ref59]^ \[Ru(*p*-cymene)Cl~2~\]~2~,^[@ref60]^ and 2-chloro-*N*-(2,6-di-*i*-propylphenyl)acetamide^[@ref59]^ were synthesized according to the procedures reported in the literature. ^1^H NMR spectra and ^13^C{^1^H} NMR spectra were recorded on Bruker 400 and 500 MHz NMR spectrometers, respectively. The multiplicities of the ^1^H NMR peaks are assigned as singlet (s), doublet (d), triplet (t), quartet (q) broad (br), triplet of triplets (tt), doublet of doublets (dd), multiplet (m), and septet (sept). A PerkinElmer Spectrum One FT-IR spectrometer was used for recording IR spectra. Mass spectrometry analysis was performed using Micromass Q-Tof and a Bruker Maxis Impact spectrometer. Elemental analysis data were obtained from the Elemental Analyzer Thermo Quest FLASH 1112 SERIES. The electronic spectra of compounds **1a**, **1b**, **2a**, **2b**, and **3a**, **3b** were recorded in CH~3~Cl using a Varian Cary UV 100 spectrophotometer. Emission spectra of compounds **1a**, **1b**, **2a**, **2b**, and **3a**, **3b** were recorded in both CH~3~Cl solution and solid state using a Varian Cary Eclipse spectrophotometer. Single-crystal X-ray diffraction study of compounds (**1**--**3**)**c** and **2b** was conducted on a Rigaku Hg 724+ diffractometer, and crystal data collection and refinement parameters are summarized in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}. The structures were solved using direct methods and standard difference map techniques and were refined by full-matrix least-squares procedures on *F*^2^ with SHELXTL (version 6.10).^[@ref61],[@ref62]^ For the catalysis runs, gas chromatography--mass spectrometry (GC--MS) analyses were done using Agilent Technologies 7890A GC systems with 5975C inert XL EI/CI MSD Triple-Axis detector and the chiral GC resolutions were done using Agilent Technologies 7890A GC systems with CP-Chirasil-Dex CB chiral column.

### Synthesis of 1-(*N*-(2,6-Di-*i*-propylphenyl)-2-acetamido)-3-(*i-*propyl)-benzimidazolium Chloride (**1a**) {#sec4.1.1}

To a stirred solution of 1-*i*-propylbenzimidazole (1.00 g, 6.24 mmol) in CH~3~CN (ca. 50 mL), 2-chloro-*N*-(2,6-di-*i*-propylphenyl)acetamide (1.64 g, 6.48 mmol) was added and the reaction mixture was refluxed overnight. After the completion of reaction, all of the volatiles were removed in vacuo and the crude mass was washed repeatedly with petroleum ether to get the product **1a** as a white solid (2.03 g, 79%). ^1^H NMR (CDCl~3~, 400 MHz, 25 °C): δ ppm, 11.10 (s, 1H, CH~2~CON[*H*]{.ul}), 10.80 (s, 1H, NC[*H*]{.ul}N of C~7~H~5~N~2~), 8.16 (d, 1H, ^3^*J*~H--H~ = 8 Hz, C~7~[*H*]{.ul}~5~N~2~), 7.71--7.69 (m, 1H, C~7~[*H*]{.ul}~5~N~2~), 7.63--7.61 (m, 2H, C~7~[*H*]{.ul}~5~N~2~), 7.19 (t, 1H, ^3^*J*~H--H~ = 8 Hz, 2,6-{(CH~3~)~2~CH}~2~C~6~[*H*]{.ul}~3~), 7.06 (d, 2H, ^3^*J*~H--H~ = 8 Hz, 2,6-{(CH~3~)~2~CH}~2~C~6~[*H*]{.ul}~3~), 5.96 (br, 2H, C[*H*]{.ul}~2~CONH), 4.88 (sept, 1H, ^3^*J*~H--H~ = 7 Hz, NC[*H*]{.ul}(CH~3~)~2~), 2.96 (sept, 2H, ^3^*J*~H--H~ = 6 Hz, 2,6-{(CH~3~)~2~C[*H*]{.ul}}~2~C~6~H~3~), 1.80 (d, 3H, ^3^*J*~H--H~ = 7 Hz, NCH(C[*H*]{.ul}~3~)~2~), 1.79 (d, 3H, ^3^*J*~H--H~ = 7 Hz, NCH(C[*H*]{.ul}~3~)~2~), 1.00 (d, 12H, ^3^*J*~H--H~ = 7 Hz, 2,6-{(C[*H*]{.ul}~3~)~2~CH}~2~C~6~H~3~). ^13^C{^1^H} NMR (CDCl~3~, 100 MHz, 25 °C): 164.3 (CH~2~NH[*C*]{.ul}O), 145.8 (N[*C*]{.ul}HN of C~7~H~5~N~2~), 141.6 (2,6-{(CH~3~)~2~CH}~2~[*C*]{.ul}~6~H~3~), 132.1 ([*C*]{.ul}~7~H~5~N~2~), 131.2 (2,6-{(CH~3~)~2~CH}~2~[*C*]{.ul}~6~H~3~), 130.3 ([*C*]{.ul}~7~H~5~N~2~), 128.0 ([*C*]{.ul}~7~H~5~N~2~), 127.1 (2,6-{(CH~3~)~2~CH}~2~[*C*]{.ul}~6~H~3~), 123.1 (2,6-{(CH~3~)~2~CH}~2~[*C*]{.ul}~6~H~3~ and [*C*]{.ul}~7~H~5~N~2~), 114.7 ([*C*]{.ul}~7~H~5~N~2~), 112.9 ([*C*]{.ul}~7~H~5~N~2~), 51.6 ([*C*]{.ul}H~2~NHCO), 50.2 (N[*C*]{.ul}H(CH~3~)~2~), 28.6 (2,6-{(CH~3~)~2~[*C*]{.ul}H}~2~C~6~H~3~), 23.9 (2,6-{([*C*]{.ul}H~3~)~2~CH}~2~C~6~H~3~), 23.2 (2,6-{([*C*]{.ul}H~3~)~2~CH}~2~C~6~H~3~), 22.1 (NCH([*C*]{.ul}H~3~)). IR data (cm^--1^) KBr pellet: 3441 (m), 3112 (m), 3058 (s), 2867 (s), 2787 (s), 1679 (s), 1547 (s), 1475 (m), 1433 (m), 1400 (m), 1376 (w), 1300 (s), 1283 (s), 1265 (s), 1198 (m), 1164 (s), 1137 (m), 1085 (m), 1061 (s), 984 (s), 963 (m), 931 (s), 888 (s), 796 (m), 766 (m), 729 (m), 692 (s), 628 (s), 598 (s), 522 (s). High-resolution mass spectrometry (HRMS) (electrospray ionization (ESI)): *m*/*z* 378.2524 \[C~24~H~32~ClN~3~O--Cl\]^+^, calcd 378.2540. Anal. calcd for C~24~H~32~ClN~3~O: C, 69.63; H, 7.79; N, 10.15; found: C, 69.27; H, 7.51; N, 10.11%.

### Synthesis of {1-(*N*-(2,6-Di-*i*-propylphenyl)-2-acetamido)-3-(*i-*propyl)-benzimidazol-2-ylidine}~2~Ag~2~ (**1b**) {#sec4.1.2}

To a solution of 1-(*N*-(2,6-di-*i*-propylphenyl)-2-acetamido)-3-(*i-*propyl)-benzimidazolium chloride (**1a**) (1.00 g, 2.41 mmol) in CH~2~Cl~2~ (ca. 50 mL), Ag~2~O (0.583 g, 2.51 mmol) was added and the reaction mixture was stirred at room temperature under dark overnight. After the completion of reaction, the reaction mixture was passed through a pad of celite, the solvent was evaporated, and the obtained solid was dried in vacuo to get the product **1b** as a gray solid (1.03 g, 88%). ^1^H NMR (CDCl~3~, 500 MHz, 25 °C): δ ppm, 8.18 (d, 1H, ^3^*J*~H--H~ = 8 Hz, C~7~*[H]{.ul}*~5~N~2~), 7.48 (d, 1H, ^3^*J*~H--H~ = 8 Hz, C~7~*[H]{.ul}*~4~N~2~), 7.35--7.33 (t, 2H, ^3^*J*~H--H~ = 5 Hz, C~7~*[H]{.ul}*~5~N~2~), 6.99 (s, 3H, 2,6-{(CH~3~)~2~CH}~2~C~6~*[H]{.ul}*~3~), 5.36 (s, 2H, C*[H]{.ul}*~2~CONH), 4.54 (sept, 1H, ^3^*J*~H--H~ = 7 Hz, NC*[H]{.ul}*(CH~3~)~2~), 2.95 (br, 2H, 2,6-{(CH~3~)~2~C*[H]{.ul}*}~2~C~6~H~3~), 1.38 (d, 6H, ^3^*J*~H--H~ = 7 Hz, NCH(C*[H]{.ul}*~3~)~2~), 0.967 (d, 6H, ^3^*J*~H--H~ = 7 Hz, 2,6-{(C*[H]{.ul}*~3~)~2~CH}~2~C~6~H~3~), 0.829 (br, 6H, 2,6-{(C*[H]{.ul}*~3~)~2~CH}~2~C~6~H~3~). ^13^C{^1^H} NMR (CDCl~3~, 100 MHz, 25 °C): 183.3 (d, ^1^*J*~C--Ag~ = 170 Hz, Ag--N*[C]{.ul}*N of C~7~H~5~N~2~), 168.5 (d, ^1^*J*~C--N~ = 10 Hz, CH~2~NH*[C]{.ul}*O), 143.6 (2,6-{(CH~3~)~2~CH}~2~*[C]{.ul}*~6~H~3~), 142.5 (2,6-{(CH~3~)~2~CH}~2~*[C]{.ul}*~6~H~3~), 134.8 (*[C]{.ul}*~7~H~5~N~2~), 134.7 (2,6-{(CH~3~)~2~CH}~2~*[C]{.ul}*~6~H~3~), 132.7 (*[C]{.ul}*~7~H~5~N~2~), 124.7 (*[C]{.ul}*~7~H~5~N~2~), 124.6 (2,6-{((CH~3~)~2~)~2~CH}~2~*[C]{.ul}*~6~H~3~), 124.2 (2,6-{(CH~3~)~2~CH}~2~*[C]{.ul}*~6~H~3~), 123.0 (2,6-{(CH~3~)~2~)~2~CH}~2~*[C]{.ul}*~6~H~3~ and (*[C]{.ul}*~7~H~5~N~2~), 115.9 (*[C]{.ul}*~7~H~5~N~2~), 111.2 (*[C]{.ul}*~7~H~5~N~2~), 60.7 (*[C]{.ul}*H~2~NHCO), 52.9 (N*[C]{.ul}*H(CH~3~)~2~), 28.1 (2,6-{(CH~3~)~2~*[C]{.ul}*H}~2~C~6~H~3~), 23.9 (2,6-{(*[C]{.ul}*H~3~)~2~CH}~2~C~6~H~3~), 23.7 (2,6-{(*[C]{.ul}*H~3~)~2~CH}~2~C~6~H~3~), 22.6 (NCH(*[C]{.ul}*H~3~)). IR data (cm^--1^) KBr pellet: 3208 (w), 3057 (w), 2958 (s), 2865 (m), 1694 (m), 1595 (s), 1575 (s), 1475 (s), 1438 (s), 1389 (s), 1256 (m), 1169 (m), 1135 (w), 1088 (m), 1057 (w), 1015 (w), 990 (w), 934 (w), 887 (w), 865 (w), 796 (m), 745 (s), 647 (w), 556 (w). Low-resolution mass spectrometry (LRMS) (ESI): *m*/*z* 968.1596 \[C~48~H~60~Ag~2~N~6~O~2~\]^+^, calcd 968.2876. Anal. calcd for C~48~H~60~Ag~2~N~6~O~2~: C, 59.51; H, 6.24; N, 8.67; found: C, 59.12; H, 5.97; N, 8.30%.

### Synthesis of \[{1-(*N*-(2,6-Di-*i*-propylphenyl)-2-acetamido)-3-(*i-*propyl)-benzimidazol-2-ylidine}Ru(*p*-cymene)Cl\]Cl (**1c**) {#sec4.1.3}

{1-(*N*-(2,6-Di-*i*-propylphenyl)-2-acetamido)-3-(*i-*propyl)-benzimidazol-2-ylidine}~2~Ag~2~ (**1b**) (0.200 g, 0.206 mmol) was taken in CH~3~CN (ca. 50 mL), to which \[Ru(*p*-cymene)Cl~2~\]~2~ (0.210 g, 0.343 mmol) was added and the reaction mixture was stirred at room temperature overnight. After completion of the reaction, the reaction mixture was passed through a pad of celite and the filtrate was evaporated. The obtained crude mass was finally purified by column chromatography using silica gel as a stationary phase and eluting with MeOH/CHCl~3~ (5:95 v/v) to get the product **1c** as a red solid (0.190 g, 67%). ^1^H NMR (CDCl~3~, 500 MHz, 25 °C): δ ppm, 12.50 (s, 1H, CH~2~CON*[H]{.ul}*), 8.29 (d, 1H, ^3^*J*~H--H~ = 9 Hz, C~7~*[H]{.ul}*~5~N~2~), 7.67 (d, 1H, ^3^*J*~H--H~ = 8 Hz, C~7~*[H]{.ul}*~5~N~2~), 7.47 (t, 1H, ^3^*J*~H--H~ = 9 Hz, C~7~*[H]{.ul}*~5~N~2~), 7.42 (t, 1H, ^3^*J*~H--H~ = 8 Hz, C~7~*[H]{.ul}*~5~N~2~), 7.35 (t, 1H, ^3^*J*~H--H~ = 8 Hz, 2,6-{(CH~3~)~2~CH}~2~C~6~*[H]{.ul}*~3~), 7.16 (d, 1H, ^3^*J*~H--H~ = 8 Hz, 2,6-{(CH~3~)~2~CH}~2~C~6~*[H]{.ul}*~3~), 7.07 (d, 1H, ^3^*J*~H--H~ = 7 Hz, 2,6-{(CH~3~)~2~CH}~2~C~6~*[H]{.ul}*~3~), 5.61--5.56 (m, 1H, (CH~3~)C~6~*[H]{.ul}*~4~{CH(CH~3~)~2~}), 5.48 (d, 1H, ^3^*J*~H--H~ = 7 Hz, (CH~3~)C~6~*[H]{.ul}*~4~{CH(CH~3~)~2~}), 5.32 (d, 1H, ^2^*J*~H--H~ = 14 Hz, C*[H]{.ul}*~2~CONH), 5.31 (d, 1H, ^2^*J*~H--H~ = 14 Hz, C*[H]{.ul}*~2~CONH), 5.18 (d, 1H, ^3^*J*~H--H~ = 7 Hz, (CH~3~)C~6~*[H]{.ul}*~4~CH(CH~3~)~2~), 5.14 (sept, ^3^*J*~H--H~ = 7 Hz, NC*[H]{.ul}*(CH~3~)~2~), 4.67 (d, 1H, ^3^*J*~H--H~ = 7 Hz, (CH~3~)C~6~*[H]{.ul}*~4~{CH(CH~3~)~2~}), 3.24 (sept, 1H, ^3^*J*~H--H~ = 7 Hz, 2,6-{(CH~3~)~2~C*[H]{.ul}*}~2~C~6~H~3~), 2.81 (sept, 1H, ^3^*J*~H--H~ = 7 Hz, 2,6-{(CH~3~)~2~C*[H]{.ul}*}~2~C~6~H~3~), 2.52 (sept, 1H, ^3^*J*~H--H~ = 7 Hz, (CH~3~)C~6~*[H]{.ul}*~4~{CH(CH~3~)~2~}), 2.16 (s, 3H, (C*[H]{.ul}*~3~)C~6~H~4~CH(CH~3~)), 1.82 (d, 3H, ^3^*J*~H--H~ = 7 Hz, NCH(C*[H]{.ul}*~3~)~2~), 1.74 (d, 3H, ^3^*J*~H--H~ = 7 Hz, NCH(C*[H]{.ul}*~3~)~2~), 1.69 (d, 3H, ^3^*J*~H--H~ = 7 Hz, 2,6-{(C*[H]{.ul}*~3~)~2~CH}~2~C~6~H~3~), 1.32 (d, 3H, ^3^*J*~H--H~ = 7 Hz, 2,6-{(C*[H]{.ul}*~3~)~2~CH}~2~C~6~H~3~), 1.21 (d, 3H, ^3^*J*~H--H~ = 7 Hz, 2,6-{(C*[H]{.ul}*~3~)~2~CH}~2~C~6~H~3~), 1.05 (d, 3H, ^3^*J*~H--H~ = 7 Hz, 2,6-{(C*[H]{.ul}*~3~)~2~CH}~2~C~6~H~3~), 0.944 (d, 3H, ^3^*J*~H--H~ = 6 Hz, (CH~3~)C~6~H~4~{CH(C*[H]{.ul}*~3~)~2~}), 0.805 (d, 3H, ^3^*J*~H--H~ = 6 Hz, (CH~3~)C~6~H~4~{CH(C*[H]{.ul}*~3~)~2~}). ^13^C{^1^H} NMR (CDCl~3~, 100 MHz, 25 °C): 188.0 (Ru--N*[C]{.ul}*N of C~7~H~5~N~2~), 171.1 (CH~2~NH*[C]{.ul}*O), 146.5 (2,6-{(CH~3~)~2~CH}~2~*[C]{.ul}*~6~H~3~), 144.7 (2,6-{(CH~3~)~2~CH}~2~*[C]{.ul}*~6~H~3~), 135.5 (2,6-{(CH~3~)~2~CH}~2~*[C]{.ul}*~6~H~3~), 132.3 (*[C]{.ul}*~7~H~5~N~2~), 128.8 (*[C]{.ul}*~7~H~5~N~2~), 124.5 (*[C]{.ul}*~7~H~5~N~2~), 123.9 (2,6-{(CH~3~)~2~CH}~2~*[C]{.ul}*~6~H~3~), 123.5 (2,6-{(CH~3~)~2~CH}~2~*[C]{.ul}*~6~H~3~), 123.1 (*[C]{.ul}*~7~H~5~N~2~), 122.9 (2,6-{(CH~3~)~2~CH}~2~*[C]{.ul}*~6~H~3~), 112.7 (*[C]{.ul}*~7~H~5~N~2~), 112.4 ((CH~3~)*[C]{.ul}*~6~H~4~{CH(CH~3~)~2~}) 110.4 (*[C]{.ul}*~7~H~5~N~2~), 102.4 ((CH~3~)*[C]{.ul}*~6~H~4~{CH(CH~3~)~2~}), 85.6 ((CH~3~)*[C]{.ul}*~6~H~4~{CH(CH~3~)~2~}), 84.7 ((CH~3~)*[C]{.ul}*~6~H~4~{CH(CH~3~)~2~}), 83.0 ((CH~3~)*[C]{.ul}*~6~H~4~{CH(CH~3~)~2~}), 80.7 ((CH~3~)*[C]{.ul}*~6~H~4~{CH(CH~3~)~2~}), 54.3 (*[C]{.ul}*H~2~NHCO), 48.4 (N*[C]{.ul}*H(CH~3~)~2~), 31.5 ((CH~3~)C~6~H~4~{*[C]{.ul}*H(CH~3~)~2~}), 29.1 ({2,6-{(CH~3~)~2~*[C]{.ul}*H}~2~C~6~H~3~), 28.5 (2,6-{(CH~3~)~2~*[C]{.ul}*H}~2~C~6~H~3~), 24.3 ({2,6-(*[C]{.ul}*H~3~)~2~CH}~2~C~6~H~3~), 24.1 (2,6-{(*[C]{.ul}*H~3~)~2~CH}~2~C~6~H~3~), 23.9 (2,6-(*[C]{.ul}*H~3~)~2~CH}~2~C~6~H~3~), 23.8 (2,6-{(*[C]{.ul}*H~3~)~2~CH}~2~C~6~H~3~), 22.3 (NCH(*[C]{.ul}*H~3~)~2~), 21.9 (NCH(*[C]{.ul}*H~3~)~2~), 20.8 ((CH~3~)C~6~H~4~{CH(*[C]{.ul}*H~3~)~2~}), 19.4 ((CH~3~)C~6~H~4~{CH(*[C]{.ul}*H~3~)~2~}). IR data (cm^--1^) KBr pellet: 3440 (m), 2963 (m), 2932 (m), 2869 (w), 1624 (s), 1477 (m), 1446 (w), 1384 (m), 1344 (m), 1291 (w), 1255 (w), 1167 (w), 1089 (w), 983 (w), 876 (w), 801 (w), 746 (m), 544 (w). HRMS (ESI): *m*/*z* 648.2287 \[C~34~H~45~Cl~2~N~3~ORu--Cl\]^+^, calcd 648.2295. Anal. calcd for C~34~H~45~Cl~2~N~3~ORu: C, 59.73; H, 6.63; N, 6.15; found: C, 59.61; H, 6.27; N, 6.64%.

### Synthesis of 1-(*N*-(2,6-Di-*i*-propylphenyl)-2-acetamido)-3-(ethyl)-benzimidazolium Chloride (**2a**) {#sec4.1.4}

To a stirred solution of 1-ethylbenzimidazole (1.00 g, 6.84 mmol) in CH~3~CN (ca. 50 mL), 2-chloro-*N*-(2,6-di-*i*-propylphenyl)acetamide (1.98 g, 7.82 mmol) was added and the reaction mixture was refluxed overnight. After completion of the reaction, all of the volatiles were removed in vacuo and the crude mass was washed repeatedly with petroleum ether to get the product **2a** as a white solid (1.93 g, 71%). ^1^H NMR (CDCl~3~, 500 MHz, 25 °C): δ ppm, 10.83 (s, 1H, NC*[H]{.ul}*N of C~7~H~5~N~2~), 10.77 (d, 1H, ^2^*J*~H--H~ = 6 Hz, CH~2~CON*[H]{.ul}*), 8.16 (d, 1H, ^3^*J*~H--H~ = 8 Hz, C~7~*[H]{.ul}*~5~N~2~), 7.68 (d, 1H, ^3^*J*~H--H~ = 8 Hz, C~7~*[H]{.ul}*~5~N~2~), 7.63--7.62 (t, 2H, ^3^*J*~H--H~ = 4 Hz, C~7~*[H]{.ul}*~5~N~2~), 7.22 (t, 1H, ^3^*J*~H--H~ = 8 Hz, 2,6-{(CH~3~)~2~CH}~2~C~6~*[H]{.ul}*~3~), 7.09 (d, 2H, ^3^*J*~H--H~ = 8 Hz, 2,6-{(CH~3~)~2~CH}~2~C~6~*[H]{.ul}*~3~), 6.05 (s, 2H, C*[H]{.ul}*~2~CONH), 4.55 (q, 2H, ^3^*J*~H--H~ = 7 Hz, NC*[H]{.ul}*~2~CH~3~), 3.05 (sept, 2H, ^3^*J*~H--H~ = 6 Hz, 2,6-{(C*[H]{.ul}*~3~)~2~CH}~2~C~6~H~3~), 1.69 (t, 3H, ^3^*J*~H--H~ = 7 Hz, NCH~2~C*[H]{.ul}*~3~), 1.01 (d, 12H, ^3^*J*~H--H~ = 7 Hz, 2,6-{(C*[H]{.ul}*~3~)~2~CH}~2~C~6~H~3~). ^13^C{^1^H} NMR (CDCl~3~, 100 MHz, 25 °C): 164.5 (CH~2~*[C]{.ul}*ONH), 146.0 (N*[C]{.ul}*HN of C~7~H~5~N~2~), 143.4 (2,6-{(CH~3~)~2~CH}~2~*[C]{.ul}*~6~H~3~), 132.3 (*[C]{.ul}*~7~H~5~N~2~), 131.2 (2,6-{(CH~3~)~2~CH}~2~*[C]{.ul}*~6~H~3~), 130.8 (*[C]{.ul}*~7~H~5~N~2~), 128.1 (*[C]{.ul}*~7~H~5~N~2~), 127.3 (2,6-{(CH~3~)~2~CH}~2~*[C]{.ul}*~6~H~3~), 127.2 (2,6-{(CH~3~)~2~CH}~2~*[C]{.ul}*~6~H~3~), 126.8 (2,6-{(CH~3~)~2~CH}~2~*[C]{.ul}*~6~H~3~), 126.4 (*[C]{.ul}*~7~H~5~N~2~), 123.2 (2,6-{(CH~3~)~2~CH}~2~*[C]{.ul}*~6~H~3~), 114.6 (*[C]{.ul}*~7~H~5~N~2~), 112.5 (*[C]{.ul}*~7~H~5~N~2~), 50.0 (*[C]{.ul}*H~2~CONH), 42.9 (N*[C]{.ul}*H~2~CH~3~), 28.7 (2,6-{(CH~3~)~2~*[C]{.ul}*H}~2~C~6~H~3~), 24.0 (2,6-{(*[C]{.ul}*H~3~)~2~CH}~2~C~6~H~3~), 23.2 (2,6-{(*[C]{.ul}*H~3~)~2~CH}~2~C~6~H~3~), 14.6 (N*C*H~2~*[C]{.ul}*H~3~). IR data (cm^--1^) KBr pellet: 3479 (w), 3117 (m), 3064 (m), 2964 (s), 2867 (m), 2803 (m), 1957 (w), 1722 (w), 1679 (s), 1608 (w), 1590 (w), 1552 (s), 1458 (m), 1439 (m), 1380 (m), 1362 (m), 1280 (m), 1255 (w), 1198 (m), 1167 (w), 1142 (w), 1085 (w), 1060 (w), 1031 (w), 967 (m), 931 (w), 886 (w), 794 (m), 771 (s), 618 (w), 546 (w), 517 (w). HRMS (ESI): *m*/*z* 364.2383 \[C~23~H~30~ClN~3~O--Cl\]^+^, calcd 364.2383. Anal. calcd for C~23~H~30~ClN~3~O: C, 69.07; H, 7.56; N, 10.51; found: C, 69.23; H, 7.14; N, 10.91%.

### Synthesis of {1-(*N*-(2,6-Di-*i*-propylphenyl)-2-acetamido)-3-(ethyl)-benzimidazol-2-ylidene}~2~Ag~2~ (**2b**) {#sec4.1.5}

1-(*N*-(2,6-Di-*i*-propylphenyl)-2-acetamido)-3-(ethyl)-benzimidazolium chloride (**2a**) (0.500 g, 1.25 mmol) was dissolved in CH~2~Cl~2~ (ca. 50 mL), to which Ag~2~O (0.721 g, 3.12 mmol) was added and the reaction mixture was stirred at room temperature under dark overnight. After the completion of reaction, the reaction mixture was passed through a pad of celite, the solvent was evaporated, and the obtained solid was dried in vacuo to get the product **2b** as a gray solid (0.531 g, 90%). ^1^H NMR (CDCl~3~, 400 MHz, 25 °C): δ ppm, 8.14--8.11 (m, 1H, C~7~*[H]{.ul}*~5~N~2~), 7.42 (d, 1H, ^3^*J*~H--H~ = 9 Hz, C~7~*[H]{.ul}*~5~N~2~), 7.41 (t, 2H, ^3^*J*~H--H~ = 7 Hz, C~7~*[H]{.ul}*~5~N~2~), 7.01 (s, 3H, 2,6-{(CH~3~)~2~CH}~2~C~6~*[H]{.ul}*~3~), 5.29 (s, 2H, ^3^*J*~H--H~ = 7 Hz, C*[H]{.ul}*~2~CONH), 4.07 (q, 2H, ^3^*J*~H--H~ = 7 Hz, NC*[H]{.ul}*~2~CH~3~), 2.95 (br, 2H, 2,6-{(CH~3~)~2~C*[H]{.ul}*}~2~C~6~H~3~), 1.22 (t, 3H, ^3^*J*~H--H~ = 7 Hz, NCH~2~C*[H]{.ul}*~3~), 0.967 (br, 12H, 2,6-{(C*[H]{.ul}*~3~)~2~CH}~2~C~6~H~3~). ^13^C{^1^H} NMR (CDCl~3~, 100 MHz, 25 °C): 186.3 (Ag--N*[C]{.ul}*N of C~7~H~5~N~2~), 168.4 (CH~2~*[C]{.ul}*ONH), 143.6 (2,6-{(CH~3~)~2~CH}~2~*[C]{.ul}*~6~H~3~), 135.0 (*[C]{.ul}*~7~H~5~N~2~), 134.4 (2,6-{(CH~3~)~2~CH}~2~*[C]{.ul}*~6~H~3~), 133.3 (*[C]{.ul}*~7~H~5~N~2~), 124.7 (*[C]{.ul}*~7~H~5~N~2~), 124.6 (2,6-{(CH~3~)~2~CH}~2~*[C]{.ul}*~6~H~3~), 123.1 (2,6-{(CH~3~)~2~CH}~2~*[C]{.ul}*~6~H~3~), 123.0 (2,6-{(CH~3~)~2~CH}~2~*[C]{.ul}*~6~H~3~ and *[C]{.ul}*~7~H~5~N~2~), 120.4 (2,6-{(CH~3~)~2~CH}~2~*[C]{.ul}*~6~H~3~), 110.3 (*[C]{.ul}*~7~H~5~N~2~), 109.8 (*[C]{.ul}*~7~H~5~N~2~), 59.8 (*[C]{.ul}*H~2~CONH), 42.3 (N*[C]{.ul}*H~2~CH~3~), 28.1 (2,6-{(CH~3~)~2~*[C]{.ul}*H}~2~C~6~H~3~), 24.0 (2,6-{(*[C]{.ul}*H~3~)~2~CH}~2~C~6~H~3~), 23.5 (2,6-{(*[C]{.ul}*H~3~)~2~CH}~2~C~6~H~3~), 15.9 (N*[C]{.ul}*H~2~CH~3~). IR data (cm^--1^) KBr pellet: 3196 (w), 3059 (w), 3030 (w), 2957 (m), 2866 (m), 1688 (w), 1601 (s), 1581 (s), 1478 (m), 1464 (m), 1436 (m), 1380 (m), 1239 (w), 1164 (w), 1085 (w), 1041 (w), 1015 (w), 989 (w), 936 (w), 860 (w), 796 (w), 747 (m), 649 (w), 562 (w), 516 (w). LRMS (ESI): *m*/*z* 963.3051 \[C~46~H~56~Ag~2~N~6~O~2~+Na\]^+^, calcd 963.2460. Anal. calcd for C~46~H~56~Ag~2~N~6~O~2~: C, 58.73; H, 6.00; N, 8.93; found: C, 58.46; H, 6.05; N, 8.76%.

### Synthesis of \[{1-(*N*-(2,6-Di-*i*-propylphenyl)-2-acetamido)-3-(ethyl)-benzimidazol-2-ylidene}Ru(*p*-cymene)Cl\]Cl (**2c**) {#sec4.1.6}

{1-(*N*-(2,6-Di-*i*-propylphenyl)-2-acetamido)-3-(ethyl)-benzimidazol-2-ylidene}~2~Ag~2~ (**2b**) (0.150 g, 0.159 mmol) was taken in CH~3~CN (ca. 50 mL), to which \[Ru(*p*-cymene)Cl~2~\]~2~ (0.192 g, 0.314 mmol) was added and the reaction mixture was stirred at room temperature overnight. After completion of the reaction, the reaction mixture was passed through a pad of celite and the filtrate was evaporated. The obtained crude mass was finally purified by column chromatography using silica gel as a stationary phase and eluting with MeOH/CHCl~3~ (5:95 v/v) to get the product **2c** as a brown solid (0.170 g, 80%). ^1^H NMR (CDCl~3~, 400 MHz, 25 °C): δ ppm, 12.40 (s, 1H, CH~2~CON*[H]{.ul}*), 8.12 (d, 1H, ^3^*J*~H--H~ = 7 Hz, C~7~*[H]{.ul}*~5~N~2~), 7.48--7.45 (m, 1H, C~7~*[H]{.ul}*~5~N~2~), 7.36 (t, 2H, ^3^*J*~H--H~ = 7 Hz,C~7~*[H]{.ul}*~5~N~2~), 7.33 (t, 1H, ^3^*J*~H--H~ = 5 Hz, 2,6-{(CH~3~)~2~CH}~2~C~6~*[H]{.ul}*~3~), 7.08 (d, 2H, ^3^*J*~H--H~ = 8 Hz, 2,6-{(CH~3~)~2~CH}~2~C~6~*[H]{.ul}*~3~), 5.48 (d, 1H, ^3^*J*~H--H~ = 7 Hz (CH~3~)C~6~*[H]{.ul}*~4~{CH(CH~3~)~2~}), 5.41 (d, 1H, ^2^*J*~H--H~ = 14 Hz, C*[H]{.ul}*~2~CONH), 5.40 (d, 1H, ^2^*J*~H--H~ = 14 Hz, C*[H]{.ul}*~2~CONH), 5.27 (d, 2H, ^3^*J*~H--H~ = 7 Hz, (CH~3~)C~6~*[H]{.ul}*~4~{CH(CH~3~)~2~}), 5.19 (d, 1H, ^3^*J*~H--H~ = 7 Hz, (CH~3~)C~6~*[H]{.ul}*~4~CH(CH~3~)~2~), 4.58 (q, 1H, ^3^*J*~H--H~ = 7 Hz, NC*[H]{.ul}*~2~CH~3~), 4.42 (q, 1H, ^3^*J*~H--H~ = 7 Hz, NC*[H]{.ul}*~2~CH~3~), 3.00 (sept, 1H, ^3^*J*~H--H~ = 7 Hz, 2,6-{(CH~3~)~2~C*[H]{.ul}*}~2~C~6~H~3~), 2.75 (sept, 1H, ^3^*J*~H--H~ = 7 Hz, 2,6-{(CH~3~)~2~C*[H]{.ul}*}~2~C~6~H~3~), 2.54 (sept, 1H, ^3^*J*~H--H~ = 7 Hz, (CH~3~)C~6~H~4~{C*[H]{.ul}*(CH~3~)~2~}), 2.12 (s, 3H, (C*[H]{.ul}*~3~)C~6~H~4~{CH(CH~3~)~2~}), 1.61 (t, 3H, ^3^*J*~H--H~ = 7 Hz, NCH~2~C*[H]{.ul}*~3~), 1.34 (d, 3H, ^3^*J*~H--H~ = 7 Hz, 2,6-{(C*[H]{.ul}*~3~)~2~CH}~2~C~6~H~3~), 1.30 (br, 3H, 2,6-{(C*[H]{.ul}*~3~)~2~CH}~2~C~6~H~3~), 1.17 (d, 3H, ^3^*J*~H--H~ = 7 Hz, 2,6-{(C*[H]{.ul}*~3~)~2~CH}~2~C~6~H~3~), 1.06 (d, 3H, ^3^*J*~H--H~ = 7 Hz, 2,6-{(C*[H]{.ul}*~3~)~2~CH}~2~C~6~H~3~), 0.956 (d, 3H, ^3^*J*~H--H~ = 6 Hz, (CH~3~)C~6~H~4~{CH(C*[H]{.ul}*~3~)~2~}), 0.827 (d, 3H, ^3^*J*~H--H~ = 6 Hz, (CH~3~)C~6~H~4~{CH(C*[H]{.ul}*~3~)~2~}). ^13^C{^1^H} NMR (CDCl~3~, 100 MHz, 25 °C): 189.1 (Ru--N*[C]{.ul}*N of C~7~H~5~N~2~), 171.1 (CH~2~NH*[C]{.ul}*O), 146.5 (2,6-{(CH~3~)~2~CH}~2~*[C]{.ul}*~6~H~3~), 144.6 (2,6-{(CH~3~)~2~CH}~2~*[C]{.ul}*~6~H~3~), 136.0 (2,6-{(CH~3~)~2~CH}~2~*[C]{.ul}*~6~H~3~), 133.8 (*[C]{.ul}*~7~H~5~N~2~), 130.1 (*[C]{.ul}*~7~H~5~N~2~), 128.8 (*[C]{.ul}*~7~H~5~N~2~), 123.9 (2,6-{(CH~3~)~2~CH}~2~*[C]{.ul}*~6~H~3~), 123.6 (2,6-{(CH~3~)~2~CH}~2~*[C]{.ul}*~6~H~3~), 123.3 (*[C]{.ul}*~7~H~5~N~2~), 122.8 (2,6-{(CH~3~)~2~CH}~2~*[C]{.ul}*~6~H~3~), 111.9 (*[C]{.ul}*~7~H~5~N~2~), 111.0 ((CH~3~)*[C]{.ul}*~6~H~4~{CH(CH~3~)~2~}) 110.7 (*[C]{.ul}*~7~H~5~N~2~), 101.1 ((CH~3~)*[C]{.ul}*~6~H~4~{CH(CH~3~)~2~}), 86.7 ((CH~3~)*[C]{.ul}*~6~H~4~{CH(CH~3~)~2~}), 86.3 ((CH~3~)*[C]{.ul}*~6~H~4~{CH(CH~3~)~2~}), 81.1 ((CH~3~)*[C]{.ul}*~6~H~4~{CH(CH~3~)~2~}), 80.9 ((CH~3~)*[C]{.ul}*~6~H~4~{CH(CH~3~)~2~}), 53.4 (*[C]{.ul}*H~2~NHCO), 48.2 (N*[C]{.ul}*H(CH~3~)~2~), 31.4 ((CH~3~)C~6~H~4~{*[C]{.ul}*H(CH~3~)~2~}), 29.0 (2,6-{(CH~3~)~2~*[C]{.ul}*H}~2~C~6~H~3~), 28.5 (2,6-{(CH~3~)~2~*[C]{.ul}*H}~2~C~6~H~3~), 24.7 (2,6-{(*[C]{.ul}*H~3~)~2~CH}~2~C~6~H~3~), 24.1 (2,6-{(*[C]{.ul}*H~3~)~2~CH}~2~C~6~H~3~), 23.9 (2,6-{(*[C]{.ul}*H~3~)~2~CH}~2~C~6~H~3~), 23.3 (2,6-{(*[C]{.ul}*H~3~)~2~CH}~2~C~6~H~3~), 23.0 (NCH~2~*[C]{.ul}*H~3~), 21.5 ((CH~3~)C~6~H~4~{CH(*[C]{.ul}*H~3~)~2~}), 19.2 ((CH~3~)C~6~H~4~{CH(*[C]{.ul}*H~3~)~2~}). IR data (cm^--1^) KBr pellet: 3445 (s), 3064 (w), 2963 (m), 2923 (m), 2869 (w), 1625 (s), 1466 (w), 1384 (m), 1341 (w), 1278 (w), 1242 (w), 1033 (m), 876 (w), 799 (w), 779 (w), 746 (m), 517 (w). HRMS (ESI): *m*/*z* 634.2135 \[C~33~H~43~Cl~2~N~3~ORu--Cl\]^+^, calcd 634.2138. Anal. calcd for C~33~H~43~Cl~2~N~3~ORu: C, 59.19; H, 6.47; N, 6.27; found: C, 58.81; H, 6.13; N, 6.39%

### Synthesis of 1-(*N*-(2,4,6-Trimethylphenyl)-2-acetamido)-3-(ethyl)-benzimidazolium Chloride (**3a**) {#sec4.1.7}

To a stirred solution of 1-ethyllbenzimidazole (1.00 g, 6.84 mmol) in CH~3~CN (ca. 50 mL), 2-chloro-*N*-mesitylacetamide (1.45 g, 6.84 mmol) was added and the reaction mixture was refluxed overnight. After completion of the reaction, all of the volatiles were removed in vacuo and the crude mass was washed repeatedly with petroleum ether to get the product **3a** as a white solid (1.87 g, 76%). ^1^H NMR (CDCl~3~, 500 MHz, 25 °C): δ ppm, 10.69 (s, 2H, CH~2~CON*[H]{.ul}* and NC*[H]{.ul}*N of C~7~H~5~N~2~), 8.08 (d, 1H, ^3^*J*~H--H~ = 7 Hz, C~7~*[H]{.ul}*~5~N~2~), 7.62 (d, 1H, ^3^*J*~H--H~ = 8 Hz, C~7~*[H]{.ul}*~5~N~2~), 7.59 (t, 2H, ^3^*J*~H--H~ = 7 Hz, C~7~*[H]{.ul}*~5~N~2~), 6.71 (s, 2H, 2,4,6-(CH~3~)~3~C~6~*[H]{.ul}*~2~), 5.99 (s, 2H, C*[H]{.ul}*~2~CONH), 4.44 (q, 2H, ^3^*J*~H--H~ = 7 Hz, NC*[H]{.ul}*~2~CH~3~), 2.16 (s, 3H, 2,4,6-(C*[H]{.ul}*~3~)~3~C~6~H~2~), 2.08 (s, 6H, 2,4,6-(C*[H]{.ul}*~3~)~3~C~6~H~2~), 1.63 (t, 3H, ^3^*J*~H--H~ = 7 Hz, NCH~2~C*[H]{.ul}*~3~). ^13^C{^1^H} NMR (CDCl~3~, 100 MHz, 25 °C): 163.5 (CH~2~*[C]{.ul}*ONH), 142.8 (N*[C]{.ul}*HN of C~7~H~5~N~2~), 136.5 (2,4,6-(CH~3~)~3~*[C]{.ul}*~6~H~3~), 135.1 (2,4,6-(CH~3~)~3~*[C]{.ul}*~6~H~3~), 134.9 (2,4,6-(CH~3~)~3~*[C]{.ul}*~6~H~3~), 132.0 (*[C]{.ul}*~7~H~5~N~2~), 131.1 (2,4,6-(CH~3~)~3~*[C]{.ul}*~6~H~3~), 130.7 (*[C]{.ul}*~7~H~5~N~2~), 128.9 (*[C]{.ul}*~7~H~5~N~2~), 128.6 (2,4,6-(CH~3~)~3~*[C]{.ul}*~6~H~3~), 127.4 (2,4,6-(CH~3~)~3~*[C]{.ul}*~6~H~3~), 127.1 (*[C]{.ul}*~7~H~5~N~2~), 114.4 (*[C]{.ul}*~7~H~5~N~2~), 112.9 (*[C]{.ul}*~7~H~5~N~2~), 49.6 (*[C]{.ul}*H~2~CONH), 42.8 (N*[C]{.ul}*H~2~CH~3~), 20.9 (2,4,6-(*[C]{.ul}*H~3~)~3~C~6~H~3~), 18.6 (2,4,6-(*[C]{.ul}*H~3~)~3~C~6~H~3~), 14.5 (NCH~2~*[C]{.ul}*H~3~). IR data (cm^--1^) KBr pellet: 3448 (s), 3144 (m), 2981 (s), 2780 (w), 1761 (m), 1690 (s), 1566 (s), 1532 (m), 1486 (m), 1431 (m), 1374 (m), 1260 (m), 1194 (m), 1167 (m), 1137 (m), 1087 (w), 1036 (m), 962 (m), 855 (m), 755 (s), 606 (w), 554 (w), 524 (w), 484 (w). HRMS (ESI): *m*/*z* 322.1924 \[C~20~H~24~ClN~3~O--Cl\]^+^, calcd 322.1914. Anal. calcd for C~20~H~24~ClN~3~O: C, 67.12; H, 6.76; N, 11.74; found: C, 66.97; H, 6.72; N, 11.57%.

### Synthesis of {1-(*N*-(2,4,6-Trimethylphenyl)-2-acetamido)-3-(ethyl)-benzimidazol-2-ylidine}~2~Ag~2~ (**3b**) {#sec4.1.8}

1-(*N*-(2,4,6-Trimethylphenyl)-2-acetamido)-3-(ethyl)-benzimidazolium chloride (**3a**) (0.500 g, 1.39 mmol) was dissolved in CH~2~Cl~2~ (ca. 50 mL), to which Ag~2~O (0.806 g, 3.49 mmol) was added and the reaction mixture was stirred at room temperature under dark overnight. After completion of the reaction, the reaction mixture was passed through a pad of celite, the solvent was evaporated, and the obtained solid was dried in vacuo to get the product **3b** as a gray solid (0.556 g, 95%). ^1^H NMR (CDCl~3~, 400 MHz, 25 °C): δ ppm, 8.02--7.73 (m, 1H, C~7~*[H]{.ul}*~4~N~2~), 7.41 (d, 1H, ^3^*J*~H--H~ = 7 Hz, C~7~*[H]{.ul}*~5~N~2~), 7.35 (t, 2H, ^3^*J*~H--H~ = 7 Hz, C~7~*[H]{.ul}*~5~N~2~), 6.68 (s, 2H, 2,4,6-(CH~3~)~3~C~6~*[H]{.ul}*~2~), 5.28 (s, 2H, C*[H]{.ul}*~2~CONH), 4.23--4.18 (m, 2H, NC*[H]{.ul}*~2~CH~3~), 2.14 (s, 3H, 2,4,6-(CH~3~)~3~C~6~*[H]{.ul}*~2~), 2.00 (s, 6H, 2,4,6-(CH~3~)~3~C~6~*[H]{.ul}*~2~), 1.54 (t, 3H, ^3^*J*~H--H~ = 7 Hz, NCH~2~C*[H]{.ul}*~3~). ^13^C{^1^H} NMR (CDCl~3~, 100 MHz, 25 °C): 189.1 (Ag--N*[C]{.ul}*N of C~7~H~5~N~2~), 171.1 (CH~2~*[C]{.ul}*ONH), 134.7 (2,4,6-(CH~3~)~3~*[C]{.ul}*~6~H~2~), 133.4 (2,4,6-(CH~3~)~3~*[C]{.ul}*~6~H~2~), 132.9 (*[C]{.ul}*~7~H~5~N~2~), 129.6 (2,4,6-(CH~3~)~3~*[C]{.ul}*~6~H~2~), 128.7 (2,4,6-(CH~3~)~3~*[C]{.ul}*~6~H~2~), 128.6 (*[C]{.ul}*~7~H~4~N~2~), 124.4 (2,4,6-(CH~3~)~3~*[C]{.ul}*~6~H~2~), 124.2 (2,4,6-(CH~3~)~3~*[C]{.ul}*~6~H~2~), 124.0 (*[C]{.ul}*~7~H~5~N~2~), 123.7 (*[C]{.ul}*~7~H~5~N~2~), 111.5 (*[C]{.ul}*~7~H~5~N~2~), 110.8 (*[C]{.ul}*~7~H~5~N~2~), 62.3 (*[C]{.ul}*H~2~CONH), 44.6 (N*[C]{.ul}*H~2~CH~3~), 20.9 (2,4,6-(*[C]{.ul}*H~3~)~3~C~6~H~2~), 18.6 (2,4,6-(*[C]{.ul}*H~3~)~3~C~6~H~2~), 16.1 (CH~2~*[C]{.ul}*H~3~). IR data (cm^--1^) KBr pellet: 3446 (m), 3190 (m), 2969 (s), 2919 (s), 2854 (m), 1687 (s), 1612 (s), 1579 (s), 1481 (s), 1433 (m), 1402 (s), 1311 (w), 1242 (m), 1190 (w), 1148 (w), 1133 (w), 1086 (m), 1040 (m), 1015 (w), 963 (w), 851 (m), 746 (s), 714 (w), 655 (w), 580 (w), 559 (w), 486 (w). LRMS (ESI): *m*/*z* 856.7491 \[C~40~H~44~Ag~2~N~6~O~2~\]^+^, calcd 856.1628. Anal. calcd for C~40~H~44~Ag~2~N~6~O~2~: C, 56.09; H, 5.18; N, 9.81; found: C, 56.46; H, 4.89; N, 9.98%.

### Synthesis of \[{1-(*N*-(2,4,6-Trimethylphenyl)-2-acetamido)-3-(ethyl)-benzimidazol-2-ylidine}Ru(*p*-cymene)Cl\]Cl (**3c**) {#sec4.1.9}

{1-(*N*-(2,4,6-Trimethylphenyl)-2-acetamido)-3-(ethyl)-benzimidazol-2-ylidine}~2~Ag~2~ (**3b**) (0.150 g, 0.175 mmol) was taken in CH~3~CN (ca. 50 mL), to which \[Ru(*p*-cymene)Cl~2~\]~2~ (0.198 g, 0.324 mmol) was added and the reaction mixture was stirred at room temperature overnight. After completion of the reaction, the reaction mixture was passed through a pad of celite and the filtrate was evaporated. The obtained crude mass was finally purified by column chromatography using silica gel as a stationary phase and eluting with MeOH/CHCl~3~ (5:95 v/v) to get the product **3c** as a brown solid (0.171 g, 78%). ^1^H NMR (CDCl~3~, 400 MHz, 25 °C): δ ppm, 12.18 (s, 1H, CH~2~CON*[H]{.ul}*), 8.10 (d, 1H, ^3^*J*~H--H~ = 8 Hz, C~7~*[H]{.ul}*~5~N~2~), 7.47 (d, 1H, ^3^*J*~H--H~ = 7 Hz, C~7~*[H]{.ul}*~5~N~2~), 7.36 (t, 2H, ^3^*J*~H--H~ = 4 Hz, C~7~*[H]{.ul}*~5~N~2~), 6.77 (s, 2H, 2,4,6-(CH~3~)~3~C~6~*[H]{.ul}*~2~), 5.58 (d, 2H, ^3^*J*~H--H~ = 6 Hz, (CH~3~)C~6~*[H]{.ul}*~4~{CH(CH~3~)~2~}), 5.47 (d, 1H, ^3^*J*~H--H~ = 5 Hz, (CH~3~)C~6~*[H]{.ul}*~4~{CH(CH~3~)~2~}), 5.38 (d, 1H, ^3^*J*~H--H~ = 5 Hz, (CH~3~)C~6~*[H]{.ul}*~4~{CH(CH~3~)~2~}), 5.18 (d, 1H, ^2^*J*~H--H~ = 15 Hz, C*[H]{.ul}*~2~CONH), 5.02 (d, 1H, ^2^*J*~H--H~ = 15 Hz, C*[H]{.ul}*~2~CONH), 4.59 (q, 1H, ^3^*J*~H--H~ = 7 Hz, NCH~2~C*[H]{.ul}*~3~), 4.45 (q, 1H, ^3^*J*~H--H~ = 7 Hz, NCH~2~C*[H]{.ul}*~3~), 2.72 (sept, 1H, ^3^*J*~H--H~ = 7 Hz, (CH~3~)C~6~H~4~{C*[H]{.ul}*(CH~3~)~2~}), 2.22 (s, 3H, 2,4,6-(C*[H]{.ul}*~3~)~3~C~6~H~2~), 2.13 (s, 3H, 2,4,6-(C*[H]{.ul}*~3~)~3~C~6~H~2~), 2.12 (s, 3H, (C*[H]{.ul}*~3~)C~6~H~4~{CH(CH~3~)~2~}), 1.99 (s, 3H, 2,4,6-(C*[H]{.ul}*~3~)~3~C~6~H~2~), 1.64 (t, 3H, ^3^*J*~H--H~ = 7 Hz, NCH~2~C*[H]{.ul}*~3~), 1.15 (d, 3H, ^3^*J*~H--H~ = 7 Hz, (CH~3~)C~6~H~4~{CH(C*[H]{.ul}*~3~)~2~}), 1.10 (d, 3H, ^3^*J*~H--H~ = 7 Hz, (CH~3~)C~6~H~4~{CH(C*[H]{.ul}*~3~)~2~}). ^13^C{^1^H} NMR (CDCl~3~, 100 MHz, 25 °C): 187.6 (Ru--N*[C]{.ul}*N of C~7~H~5~N~2~), 169.8 (CH~2~NH*[C]{.ul}*O), 137.2 (2,4,6-(CH~3~)~3~*[C]{.ul}*~6~H~2~), 135.3 (2,4,6-(CH~3~)~3~*[C]{.ul}*~6~H~2~), 132.1 (*[C]{.ul}*~7~H~5~N~2~), 129.8 (2,4,6-(CH~3~)~3~*[C]{.ul}*~6~H~2~), 130.1 (*[C]{.ul}*~7~H~5~N~2~), 128.7 (2,4,6-(CH~3~)~3~*[C]{.ul}*~6~H~2~), 124.2 (*[C]{.ul}*~7~H~5~N~2~), 123.3 (*[C]{.ul}*~7~H~5~N~2~), 112.4 (*[C]{.ul}*~7~H~5~N~2~), 112.2 ((CH~3~)*[C]{.ul}*~6~H~4~{CH(CH~3~)~2~}) 109.7 (*[C]{.ul}*~7~H~5~N~2~), 100.8 ((CH~3~)*[C]{.ul}*~6~H~4~{CH(CH~3~)~2~}), 84.9 ((CH~3~)*[C]{.ul}*~6~H~4~{CH(CH~3~)~2~}), 84.9 ((CH~3~)*[C]{.ul}*~6~H~4~{CH(CH~3~)~2~}), 84.5 ((CH~3~)*[C]{.ul}*~6~H~4~{CH(CH~3~)~2~}), 80.9 ((CH~3~)*[C]{.ul}*~6~H~4~{CH(CH~3~)~2~}), 54.1 (*[C]{.ul}*H~2~NHCO), 48.3 (N*[C]{.ul}*H~2~CH~3~), 31.5 ((CH~3~)C~6~H~4~{*[C]{.ul}*H(CH~3~)~2~}), 23.9 (2,4,6-(*[C]{.ul}*H~3~)~3~C~6~H~2~), 23.2 (2,4,6-(*[C]{.ul}*H~3~)~3~C~6~H~2~), 21.8 (2,4,6-(*[C]{.ul}*H~3~)~3~C~6~H~2~), 21.0 (NCH~2~*[C]{.ul}*H~3~), 20.9 ((CH~3~)C~6~H~4~{CH(*[C]{.ul}*H~3~)~2~}), 18.8 ((CH~3~)C~6~H~4~{CH(*[C]{.ul}*H~3~)~2~}). IR data (cm^--1^) KBr pellet: 3446 (m), 3054 (w), 2964 (m), 2922 (m), 2874 (m), 1627 (s), 1482 (m), 1445 (m), 1408 (m), 1384 (m), 1346 (m), 1277 (w), 1243 (w), 1215 (w), 1173 (w), 1136 (w), 1085 (w), 1036 (w), 988 (w), 855 (w), 749 (m), 672 (w), 610 (w), 558 (w). HRMS (ESI): *m*/*z* 592.1661 \[C~30~H~37~Cl~2~N~3~ORu--Cl\]^+^, calcd 592.1668. Anal. calcd for C~30~H~37~Cl~2~N~3~ORu: C, 57.41; H, 5.94; N, 6.70; found: C, 57.15; H, 5.77; N, 6.79%.

General Procedure of Photoluminescence Studies {#sec4.2}
----------------------------------------------

Using a Varian Cary Eclipse spectrophotometer, emission spectra of compounds **1a**, **1b**, **2a**, **2b**, and **3a**, **3b** were recorded in CH~3~Cl solution (0.001 M) at 25 °C upon excitation at 270 nm in quartz cuvettes. The solid-state experiment was performed for the respective compounds **1a**, **1b**, **2a**, **2b**, and **3a**, **3b** by mixing with NaCl in the ratio of 1:100 and then grinding the mixture to a powder before recording the emission spectra at 25 °C upon excitation at 270 nm in quartz glass slab.

General Procedure for Cyanosilylation of Aldehydes Using Ruthenium (**1**--**3**)**c** Complexes {#sec4.3}
------------------------------------------------------------------------------------------------

Ruthenium (**1--3**)**c** complexes (0.02 mmol, 2 mol %), aryl aldehyde substrate (1.00 mmol), and TMSCN (3 mmol) were mixed, and the resultant solution was stirred for 6 h at room temperature. All volatiles were then removed in vacuo, and the crude product was purified by column chromatography using neutral Al~2~O~3~ as a stationary phase and eluting with petroleum ether/EtOAc (99:1--70:30 v/v) to give the cyanosilylated product (**4**--**13**).

Procedure for the Control Experiment Using \[Ru(*p*-cymene)Cl\]~2~ {#sec4.4}
------------------------------------------------------------------

A mixture of \[Ru(*p*-cymene)Cl\]~2~ (0.010 mmol, 1 mol %), benzaldehyde substrate (1.00 mmol), and TMSCN (3.00 mmol) was stirred for 6 h at room temperature. All volatiles were then removed in vacuo, and the crude product was purified by column chromatography using neutral Al~2~O~3~ as a stationary phase and eluting with petroleum ether/EtOAc (99:1 v/v) to give the desired cyanosilylated product **4** as a colorless liquid (yield: 0.060 g, 30%).

### Synthesis of 2-Phenyl-2-(trimethylsilyloxy)acetonitrile (**4**) {#sec4.4.1}

![](ao-2017-02090s_0010){#fx3}

Ruthenium (**1**--**3**)**c** complexes (0.020 mmol, 2 mol %), benzaldehyde (1.00 mmol), and TMSCN (3.00 mmol) were mixed, and the resultant solution was stirred for 6 h at room temperature. All volatiles were then removed in vacuo, and the crude product was purified by column chromatography using neutral Al~2~O~3~ as a stationary phase and eluting with petroleum ether/EtOAc (99:1 v/v) to give the desired cyanosilylated product **4** as a colorless liquid.

Yields: 0.178 g, 87% (**1c**); 0.166 g, 81% (**2c**); 0.157 g, 77% (**3c**).

^1^H NMR (CDCl~3~, 500 MHz, 25 °C): δ 7.48--7.47 (m, 1H, C~6~*[H]{.ul}*~5~), 7.47--7.46 (m, 1H, C~6~*[H]{.ul}*~5~), 7.44--7.42 (m, 1H, C~6~*[H]{.ul}*~5~), 7.41--7.39 (m, 1H, C~6~*[H]{.ul}*~5~), 5.49 (s, 1H, C*[H]{.ul}*), 0.233 (s, 9H, O--Si(C*[H]{.ul}*~3~)~3~). ^13^C{^1^H} NMR (CDCl~3~, 100 MHz, 25 °C): δ 136.5 (*[C]{.ul}*N), 129.5 (*[C]{.ul}*~6~H~5~), 129.1 (*[C]{.ul}*~6~H~5~), 126.6 (*[C]{.ul}*~6~H~5~), 119.4 (*[C]{.ul}*~6~H~5~), 63.9 (*[C]{.ul}*H), −0.06 (O--Si(*[C]{.ul}*H~3~)~3~). Anal. calcd for C~11~H~15~NOSi: C, 64.35; H, 7.36; N, 6.82; found: C, 64.55; H, 7.32; N, 6.66%. GC--MS (ESI): *m*/*z* = 205 \[M\]^+^. GC \[CP-Chirasil-Dex CB, column temperature = 110 °C (isothermal), inject temperature = 230 °C, detector temperature = 250 °C\]: *t*~R~ = 39.3 min, *t*~R~ = 38.3 min.

### Synthesis of 2-(*p*-Tolyl)-2-((trimethylsilyl)oxy)acetonitrile (**5**) {#sec4.4.2}

![](ao-2017-02090s_0012){#fx4}

Ruthenium (**1**--**3**)**c** complexes (0.020 mmol, 2 mol %), 4-methylbenzaldehyde (1.00 mmol), and TMSCN (3.00 mmol) were mixed, and the resultant solution was stirred for 6 h at room temperature. All volatiles were then removed in vacuo, and the crude product was purified by column chromatography using neutral Al~2~O~3~ as a stationary phase and eluting with petroleum ether/EtOAc (99:1 v/v) to give the desired cyanosilylated product **5** as a colorless liquid.

Yields: 0.175 g, 80% (**1c**); 0.164 g, 75% (**2c**); 0.145 g, 66% (**3c**).

^1^H NMR (CDCl~3~, 400 MHz, 25 °C): δ 7.35 (d, 2H, ^3^*J*~H--H~ = 8 Hz, 4-(CH~3~)C~6~*[H]{.ul}*~4~), 7.21 (d, 2H, ^3^*J*~H--H~ = 8 Hz, 4-(CH~3~)C~6~*[H]{.ul}*~4~), 5.46 (s, 1H, C*[H]{.ul}*), 2.37 (s, 3H, 4-(C*[H]{.ul}*~3~)C~6~H~4~), 0.222 (s, 9H, O--Si(C*[H]{.ul}*~3~)~3~). ^13^C{^1^H} NMR (CDCl~3~, 100 MHz, 25 °C): δ 139.6 (*[C]{.ul}*N), 133.6 (4-(CH~3~)*[C]{.ul}*~6~H~4~), 129.8 (4-(CH~3~)*[C]{.ul}*~6~H~4~), 126.6 (4-(CH~3~)*[C]{.ul}*~6~H~4~), 119.5 (4-(CH~3~)*[C]{.ul}*~6~H~4~), 63.8 (*[C]{.ul}*H), 21.4 (4-(*[C]{.ul}*H~3~)C~6~H~4~), −0.05 (O--Si(*[C]{.ul}*H~3~)~3~). Anal. calcd for C~12~H~17~NOSi: C, 65.71; H, 7.81; N, 6.39; found: C, 65.38; H, 7.63; N, 6.50%.GC--MS (ESI): *m*/*z* = 219 \[M\]^+^. GC \[CP-Chirasil-Dex CB, column temperature = 95 °C (isothermal), inject temperature = 250 °C, detector temperature = 280 °C\]: *t*~R~ = 118.6 min, *t*~R~ = 122.0 min.

### Synthesis of 2-(3-Methoxyphenyl)-2-((trimethylsilyl)oxy)acetonitrile (**6**) {#sec4.4.3}

![](ao-2017-02090s_0013){#fx5}

Ruthenium (**1**--**3**)**c** complexes (0.020 mmol, 2 mol %), 3-methoxybenzaldehyde (1.00 mmol), and TMSCN (3.00 mmol) were mixed, and the resultant solution was stirred for 6 h at room temperature. All volatiles were then removed in vacuo, and the crude product was purified by column chromatography using neutral Al~2~O~3~ as a stationary phase and eluting with petroleum ether/EtOAc (98:2 v/v) to give the desired cyanosilylated product **6** as a colorless liquid.

Yields: 0.180 g, 77% (**1c**); 0.155 g, 66% (**2c**); 0.162 g, 69% (**3c**).

^1^H NMR (CDCl~3~, 400 MHz, 25 °C): δ 7.32 (t, 1H, ^3^*J*~H--H~ = 8 Hz, 3-(CH~3~O)C~6~*[H]{.ul}*~4~), 7.04--7.01 (m, 2H, 3-(CH~3~O)C~6~*[H]{.ul}*~4~), 6.93--6.90 (m, 1H, 3-(CH~3~O)C~6~*[H]{.ul}*~4~), 5.46 (s, 1H, C*[H]{.ul}*), 3.83 (s, 3H, 3-(C*[H]{.ul}*~3~O)C~6~H~4~), 0.236 (s, 9H, O--Si(C*[H]{.ul}*~3~)~3~). ^13^C{^1^H} NMR (CDCl~3~, 100 MHz, 25 °C): δ 160.2 (*[C]{.ul}*N), 137.9 (3-(CH~3~O)*[C]{.ul}*~6~H~4~), 130.2 (3-(CH~3~O)*[C]{.ul}*~6~H~4~), 119.3 (3-(CH~3~O)*[C]{.ul}*~6~H~4~), 118.7 (3-(CH~3~O)*[C]{.ul}*~6~H~4~), 115.1 (3-(CH~3~O)*[C]{.ul}*~6~H~4~), 112.1 (3-(CH~3~O)*[C]{.ul}*~6~H~4~), 63.7 (*[C]{.ul}*H), 55.5 (3-(*[C]{.ul}*H~3~O)C~6~H~4~), −0.06 (O--Si(*[C]{.ul}*H~3~)~3~). Anal. calcd for C~12~H~17~NO~2~Si: C, 61.24; H, 7.28; N, 5.95; found: C, 61.23; H, 6.91; N, 5.80%. GC--MS (ESI): *m*/*z* = 235 \[M\]^+^. GC \[CP-Chirasil-Dex CB, column temperature = 100 °C (isothermal), inject temperature = 230 °C, detector temperature = 250 °C\]: *t*~R~ = 259.7 min, *t*~R~ = 264.7 min.

### Synthesis of 2-(4-Methoxyphenyl)-2-((trimethylsilyl)oxy)acetonitrile (**7**) {#sec4.4.4}

![](ao-2017-02090s_0014){#fx6}

Ruthenium (**1**--**3**)**c** complexes (0.020 mmol, 2 mol %), 4-methoxybenzaldehyde (1.00 mmol), and TMSCN (3.00 mmol) were mixed, and the resultant solution was stirred for 6 h at room temperature. All volatiles were then removed in vacuo, and the crude product was purified by column chromatography using neutral Al~2~O~3~ as a stationary phase and eluting with petroleum ether/EtOAc (98:2 v/v) to give the desired cyanosilylated product **7** as a colorless liquid.

Yields: 0.179 g, 76% (**1c**); 0.174 g, 74% (**2c**); 0.172 g, 73% (**3c**).

^1^H NMR (CDCl~3~, 500 MHz, 25 °C): δ 7.38 (d, 2H, ^3^*J*~H--H~ = 9 Hz, 4-(CH~3~O)~2~C~6~*[H]{.ul}*~4~), 6.92 (d, 2H, ^3^*J*~H--H~ = 9 Hz, 4-(CH~3~O)~2~C~6~*[H]{.ul}*~4~), 5.46 (s, 1H, C*[H]{.ul}*), 3.82 (s, 3H, 4-(C*[H]{.ul}*~3~O)C~6~H~4~), 0.210 (s, 9H, O--Si(C*[H]{.ul}*~3~)~3~). ^13^C{^1^H} NMR (CDCl~3~, 100 MHz, 25 °C): δ 160.5 (*[C]{.ul}*N), 128.7 (4-(CH~3~O)*[C]{.ul}*~6~H~4~), 128.1 (4-(CH~3~O)*[C]{.ul}*~6~H~4~), 119.5 (4-(CH~3~O)*[C]{.ul}*~6~H~4~), 114.5 (4-(CH~3~O)*[C]{.ul}*~6~H~4~), 63.6 (*[C]{.ul}*H), 55.5 (4-(*[C]{.ul}*H~3~O)C~6~H~4~), −0.04 (O--Si(*[C]{.ul}*H~3~)~3~). Anal. calcd for C~12~H~17~NO~2~Si: C, 61.24; H, 7.28; N, 5.95; found: C, 61.02; H, 7.35; N, 6.25%. GC--MS (ESI): *m*/*z* = 235 \[M\]^+^. GC \[CP-Chirasil-Dex CB, column temperature = 110 °C (isothermal), inject temperature = 230 °C, detector temperature = 250 °C\]: *t*~R~ = 187.3 min, *t*~R~ = 192.1 min.

### Synthesis of 2-(2,5-Dimethoxyphenyl)-2-((trimethylsilyl)oxy)acetonitrile (**8**) {#sec4.4.5}

![](ao-2017-02090s_0015){#fx7}

Ruthenium (**1**--**3**)**c** complexes (0.020 mmol, 2 mol %), 2,5-dimethoxybenzaldehyde (1.00 mmol), and TMSCN (3.00 mmol) were mixed, and the resultant solution was stirred for 6 h at room temperature. All volatiles were then removed in vacuo, and the crude product was purified by column chromatography using neutral Al~2~O~3~ as a stationary phase and eluting with petroleum ether/EtOAc (96:4 v/v) to give the desired cyanosilylated product **8** as a colorless liquid.

Yields: 0.215 g, 81% (**1c**); 0.201 g, 76% (**2c**); 0.199 g, 75% (**3c**).

^1^H NMR (CDCl~3~, 500 MHz, 25 °C): δ 7.16 (d, 1H, ^3^*J*~H--H~ = 3 Hz, 2,5-(CH~3~O)~2~C~6~*[H]{.ul}*~3~), 6.88--6.86 (m, 1H, 2,5-(CH~3~O)~2~C~6~*[H]{.ul}*~3~), 6.83 (s, 1H, 2,5-(CH~3~O)~2~C~6~*[H]{.ul}*~3~), 5.76 (s, 1H, C*[H]{.ul}*), 3.83 (s, 3H, 2,5-(C*[H]{.ul}*~3~O)~2~C~6~H~3~), 3.79 (s, 3H, 2,5-(C*[H]{.ul}*~3~O)~2~C~6~H~3~), 0.229 (s, 9H, O--Si(C*[H]{.ul}*~3~)~3~). ^13^C{^1^H} NMR (CDCl~3~, 100 MHz, 25 °C): δ 154.0 (*[C]{.ul}*N), 150.1 (2,5-(CH~3~O)~2~*[C]{.ul}*~6~H~3~), 125.6 (2,5-(CH~3~O)~2~*[C]{.ul}*~6~H~3~), 119.4 (2,5-(CH~3~O)~2~*[C]{.ul}*~6~H~3~), 115.3 (2,5-(CH~3~O)~2~*[C]{.ul}*~6~H~3~), 113.3 (2,5-(CH~3~O)~2~*[C]{.ul}*~6~H~3~), 111.9 (2,5-(CH~3~O)~2~*[C]{.ul}*~6~H~3~), 58.3 (*[C]{.ul}*H), 56.1 (2,5-(*[C]{.ul}*H~3~O)~2~C~6~H~3~), 56.0 (2,5-(*[C]{.ul}*H~3~O)~2~C~6~H~3~), −0.17 (O--Si(*[C]{.ul}*H~3~)~3~). Anal. calcd for C~13~H~19~NO~3~Si: C, 58.84; H, 7.22; N, 5.28; found: C, 59.59; H, 7.01; N, 5.36%. GC--MS (ESI): *m*/*z* = 265 \[M\]^+^. GC \[CP-Chirasil-Dex CB, column temperature = 100 °C (isothermal), inject temperature = 230 °C, detector temperature = 250 °C\]: *t*~R~ = 194.3 min, *t*~R~ = 199.2 min.

### Synthesis of 2-(3,4-Dimethoxyphenyl)-2-((trimethylsilyl)oxy)acetonitrile (**9**) {#sec4.4.6}

![](ao-2017-02090s_0018){#fx8}

Ruthenium (**1**--**3**)**c** complexes (0.020 mmol, 2 mol %), 3,4-dimethoxybenzaldehyde (1.00 mmol), and TMSCN (3.00 mmol) were mixed, and the resultant solution was stirred for 6 h at room temperature. All volatiles were then removed in vacuo, and the crude product was purified by column chromatography using neutral Al~2~O~3~ as a stationary phase and eluting with petroleum ether/EtOAc (96:4 v/v) to give the desired cyanosilylated product **9** as a colorless liquid.

Yields: 0.204 g, 77% (**1c**); 0.178 g, 67% (**2c**); 0.159 g, 60% (**3c**).

^1^H NMR (CDCl~3~, 400 MHz, 25 °C): δ 6.98 (d, 1H, ^3^*J*~H--H~ = 7 Hz, 3,4-(CH~3~O)~2~C~6~*[H]{.ul}*~3~), 6.97 (d, 1H, ^3^*J*~H--H~ = 7 Hz, 3,4-(CH~3~O)~2~C~6~*[H]{.ul}*~3~), 6.87--6.85 (m, 1H, 3,4-(CH~3~O)~2~C~6~*[H]{.ul}*~3~), 5.42 (s, 1H, C*[H]{.ul}*), 3.90 (s, 3H, 3,4-(C*[H]{.ul}*~3~O)~2~C~6~H~3~), 3.88 (s, 3H, 3,4-(C*[H]{.ul}*~3~O)~2~C~6~H~3~), 0.212 (s, 9H, O--Si(C*[H]{.ul}*~3~)~3~). ^13^C{^1^H} NMR (CDCl~3~, 100 MHz, 25 °C): δ 150.1 (*[C]{.ul}*N), 149.6 (3,4-(CH~3~O)~2~*[C]{.ul}*~6~H~3~), 128.9 (3,4-(CH~3~O)~2~*[C]{.ul}*~6~H~3~), 119.4 (3,4-(CH~3~O)~2~*[C]{.ul}*~6~H~3~), 119.3 (3,4-(CH~3~O)~2~*[C]{.ul}*~6~H~3~), 111.2 (3,4-(CH~3~O)~2~*[C]{.ul}*~6~H~3~), 109.6 (3,4-(CH~3~O)~2~*[C]{.ul}*~6~H~3~), 63.8 (*[C]{.ul}*H), 56.1 (3,4-(*[C]{.ul}*H~3~O)~2~C~6~H~3~), 56.1 (3,4-(*[C]{.ul}*H~3~O)~2~C~6~H~3~), −0.04 (O--Si(*[C]{.ul}*H~3~)~3~). Anal. calcd for C~13~H~19~NO~3~Si: C, 58.84; H, 7.22; N, 5.28; found: C, 59.67; H, 6.78; N, 5.39%. GC--MS (ESI): *m*/*z* = 265 \[M\]^+^. GC \[CP-Chirasil-Dex CB, column temperature = 100 °C (isothermal), inject temperature = 230 °C, detector temperature = 250 °C\]: *t*~R~ = 195.4 min, *t*~R~ = 200.1 min.

### Synthesis of 2-(2,4,5-Trimethoxyphenyl)-2-((trimethylsilyl)oxy)acetonitrile (**10**) {#sec4.4.7}

![](ao-2017-02090s_0019){#fx9}

Ruthenium (**1**--**3**)**c** complexes (0.020 mmol, 2 mol %), 2,4,5-trimethoxybenzaldehyde (1.00 mmol), and TMSCN (3.00 mmol) were mixed, and the resultant solution was stirred for 6 h at room temperature. All volatiles were then removed in vacuo, and the crude product was purified by column chromatography using neutral Al~2~O~3~ as a stationary phase and eluting with petroleum ether/EtOAc (70:30 v/v) to give the desired cyanosilylated product **10** as a colorless liquid.

Yields: 0.280 g, 95% (**1c**); 0.278 g, 94% (**2c**); 0.271 g, 92% (**3c**).

^1^H NMR (CDCl~3~, 500 MHz, 25 °C): δ 7.11 (s, 1H, 2,4,5-(CH~3~O)~3~C~6~*[H]{.ul}*~2~), 6.50 (s, 1H, 2,4,5-(CH~3~O)~3~C~6~*[H]{.ul}*~2~), 5.79 (s, 1H, C*[H]{.ul}*), 3.90 (s, 3H, 2,4,5-(C*[H]{.ul}*~3~O)~3~C~6~H~2~), 3.87 (s, 3H, 2,4,5-(C*[H]{.ul}*~3~O)~3~C~6~H~2~), 3.85 (s, 3H, 2,4,5-(CH~3~O)~3~C~6~*[H]{.ul}*~2~), 0.212 (s, 9H, (O--Si(C*[H]{.ul}*~3~)~3~)). ^13^C{^1^H} NMR (CDCl~3~, 100 MHz, 25 °C): δ 150.8 (*[C]{.ul}*N), 150.5 (2,4,5-(CH~3~O)~3~*[C]{.ul}*~6~H~2~), 143.6 (2,4,5-(CH~3~O)~3~*[C]{.ul}*~6~H~2~), 119.7 (2,4,5-(CH~3~O)~3~*[C]{.ul}*~6~H~2~), 116.1 (2,4,5-(CH~3~O)~3~*[C]{.ul}*~6~H~2~), 111.3 (2,4,5-(CH~3~O)~3~*[C]{.ul}*~6~H~2~), 97.1 (2,4,5-(CH~3~O)~3~*[C]{.ul}*~6~H~2~), 58.0 (*[C]{.ul}*H), 56.7 (2,4,5-(*[C]{.ul}*H~3~O)~3~C~6~H~2~), 56.4 (2,4,5-(*[C]{.ul}*H~3~O)~3~C~6~H~2~), 56.3 (2,4,5-(*[C]{.ul}*H~3~O)~3~C~6~H~2~), −0.12 (O--Si(*[C]{.ul}*H~3~)~3~). Anal. calcd for C~14~H~21~NO~4~Si: C, 56.92; H, 7.17; N, 4.74; found: C, 57.31; H, 7.45; N, 4.55%. GC--MS (ESI): *m*/*z* = 295 \[M\]^+^. GC \[CP-Chirasil-Dex CB, column temperature = 125 °C (isothermal), inject temperature = 160 °C, detector temperature = 200 °C\]: *t*~R~ = 315.8 min, *t*~R~ = 330.4 min.

### Synthesis of 2-(Pyridin-2-yl)-2-((trimethylsilyl)oxy)acetonitrile (**11**) {#sec4.4.8}

![](ao-2017-02090s_0020){#fx10}

Ruthenium (**1**--**3**)**c** complexes (0.020 mmol, 2 mol %), picolinaldehyde (1.00 mmol), and TMSCN (3.00 mmol) were mixed, and the resultant solution was stirred for 6 h at room temperature. All volatiles were then removed in vacuo, and the crude product was purified by column chromatography using neutral Al~2~O~3~ as a stationary phase and eluting with petroleum ether/EtOAc (80:20 v/v) to give the desired cyanosilylated product **11** as a colorless liquid.

Yields: 0.196 g, 95% (**1c**); 0.196 g, 95% (**2c**); 0.185 g, 90% (**3c**).

^1^H NMR (CDCl~3~, 400 MHz, 25 °C): δ 8.59 (d, 1H, ^3^*J*~H--H~ = 6 Hz, C~6~*[H]{.ul}*~4~N), 7.79 (t, 1H, ^3^*J*~H--H~ = 8 Hz, C~6~*[H]{.ul}*~4~N), 7.59 (d, 1H, ^3^*J*~H--H~ = 8 Hz, C~6~*[H]{.ul}*~4~N), 7.31--7.28 (m, 1H, C~6~*[H]{.ul}*~4~N), 5.58 (s, 1H, C*[H]{.ul}*), 0.258 (s, 9H, O--Si(C*[H]{.ul}*~3~)~3~). ^13^C{^1^H} NMR (CDCl~3~, 100 MHz, 25 °C): δ 155.6 (*[C]{.ul}*N), 149.6 (*[C]{.ul}*~6~H~4~N), 137.7 (*[C]{.ul}*~6~H~4~N), 124.2 (*[C]{.ul}*~6~H~4~N), 120.7 (*[C]{.ul}*~6~H~4~N), 118.8 (*[C]{.ul}*~6~H~4~N), 65.3 (*[C]{.ul}*H), −0.17 (O--Si(*[C]{.ul}*H~3~)~3~). Anal. calcd for C~10~H~14~N~2~OSi·1/4H~2~O: C, 56.97; H, 6.93; N, 13.29; found: C, 57.10; H, 6.57; N, 12.92%. GC--MS (ESI): *m*/*z* = 206 \[M\]^+^. GC \[CP-Chirasil-Dex CB, column temperature = 120 °C (isothermal), inject temperature = 160 °C, detector temperature = 200 °C\]: *t*~R~ = 29.8 min, *t*~R~ = 30.5 min.

### Synthesis of 2-(Furan-2-yl)-2-((trimethylsilyl)oxy)acetonitrile (**12**) {#sec4.4.9}

![](ao-2017-02090s_0022){#fx11}

Ruthenium (**1**--**3**)**c** complexes (0.020 mmol, 2 mol %), furan-2-carbaldehyde (1.00 mmol), and TMSCN (3.00 mmol) were mixed, and the resultant solution was stirred for 6 h at room temperature. All volatiles were then removed in vacuo, and the crude product was purified by column chromatography using neutral Al~2~O~3~ as a stationary phase and eluting with petroleum ether/EtOAc (90:10 v/v) to give the desired cyanosilylated product **12** as a colorless liquid.

Yields: 0.146 g, 75% (**1c**); 0.140 g, 72% (**2c**); 0.146 g, 75% (**3c**).

^1^H NMR (CDCl~3~, 500 MHz, 25 °C): δ 7.46--7.45 (m, 1H, C~4~*[H]{.ul}*~3~O), 6.54 (d, 1H, ^3^*J*~H--H~ = 3 Hz, C~4~*[H]{.ul}*~3~O), 6.40--6.39 (m, 1H, C~4~*[H]{.ul}*~3~O), 5.53 (s, 1H, C*[H]{.ul}*), 0.197 (s, 9H, O--Si(C*[H]{.ul}*~3~)~3~). ^13^C{^1^H} NMR (CDCl~3~, 100 MHz, 25 °C): δ 148.5 (*[C]{.ul}*N), 144.1 (*[C]{.ul}*~4~H~3~O), 117.3 (*[C]{.ul}*~4~H~3~O), 111.0 (*[C]{.ul}*~4~H~3~O), 109.3 (*[C]{.ul}*~4~H~3~O), 57.7 (*[C]{.ul}*H), −0.17 (O--Si(*[C]{.ul}*H~3~)~3~). Anal. calcd for C~9~H~13~NO~2~Si·1/5CHCl~3~: C, 50.42; H, 6.07; N, 6.39; found: C, 50.77; H, 5.89; N, 7.08%. GC--MS (ESI): *m*/*z* = 195 \[M\]^+^. GC \[CP-Chirasil-Dex CB, column temperature = 120 °C (isothermal), inject temperature = 160 °C, detector temperature = 200 °C\]: *t*~R~ = 11.4 min, *t*~R~ = 12.3 min.

### Synthesis of 2-(Thiophen-2-yl)-2-((trimethylsilyl)oxy)acetonitrile (**13**) {#sec4.4.10}

![](ao-2017-02090s_0011){#fx12}

Ruthenium (**1**--**3**)**c** complexes (0.020 mmol, 2 mol %), thiophene-2-carbaldehyde (1.00 mmol), and TMSCN (3.00 mmol) were mixed, and the resultant solution was stirred for 6 h at room temperature. All volatiles were then removed in vacuo, and the crude product was purified by column chromatography using neutral Al~2~O~3~ as a stationary phase and eluting with petroleum ether/EtOAc (90:10 v/v) to give the desired cyanosilylated product **13** as a colorless liquid.

Yields: 0.179 g, 85% (**1c**); 0.192 g, 91% (**2c**); 0.179 g, 85% (**3c**).

^1^H NMR (CDCl~3~, 500 MHz, 25 °C): δ 7.36 (dd, 1H, ^3^*J*~H--H~ = 7 Hz, ^4^*J*~H--H~ = 2 Hz, C~4~*[H]{.ul}*~3~S), 7.19 (tt, 1H, ^3^*J*~H--H~ = 5 Hz, ^4^*J*~H--H~ = 1 Hz, C~4~*[H]{.ul}*~3~S), 7.01--6.99 (m, 1H, C~4~*[H]{.ul}*~3~S), 5.73 (s, 1H, C*[H]{.ul}*), 0.236 (s, 9H, O--Si(C*[H]{.ul}*~3~)~3~). ^13^C{^1^H} NMR (CDCl~3~, 100 MHz, 25 °C): δ 139.7 (*[C]{.ul}*N), 127.4 (*[C]{.ul}*~4~H~3~S), 127.1 (*[C]{.ul}*~4~H~3~S), 126.5 (*[C]{.ul}*~4~H~3~S), 118.5 (*[C]{.ul}*~4~H~3~S), 59.7 (*[C]{.ul}*H), −0.11 (O--Si(*[C]{.ul}*H~3~)~3~). Anal. calcd for C~9~H~13~NOSSi·1/6CHCl~3~: C, 47.61; H, 5.74; N, 6.06; S, 13.86; found: C, 47.49; H, 5.43; N, 6.61; S, 14.07%. GC--MS (ESI): *m*/*z* = 211 \[M\]^+^. GC \[CP-Chirasil-Dex CB, column temperature = 120 °C (isothermal), inject temperature = 160 °C, detector temperature = 200 °C\]: *t*~R~ = 25.6 min, *t*~R~ = 27.4 min.

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acsomega.7b02090](http://pubs.acs.org/doi/abs/10.1021/acsomega.7b02090).^1^H NMR, ^13^C{^1^H} NMR, IR, HRMS, CHNS, data of the compounds (**1**--**3**)**a**, (**1**--**3**)**b**, and (**1**--**3**)**c**, GC and GC--MS of the catalysis products **4**--**13**; absorbance and emission data of the compounds (**1**--**3**)**a** and (**1**--**3**)**b** ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b02090/suppl_file/ao7b02090_si_001.pdf))X-ray crystallographic data of the ruthenium (**1**--**3**)**c** complexes and silver **2b**; CCDC 1524131 (**1c**), 1536819 (**2c**), 1524134 (**3c**), and 1524130 (**2b**) ([CIF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b02090/suppl_file/ao7b02090_si_002.cif))
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